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Abstract
Gamma-Secretase (γ-secretase) is a transmembrane protease of increasing interest, which
has been shown to have significant connections to both cancer and Alzheimer’s disease. γsecretase cleaves both Notch-1, a transmembrane signaling protein, and Amyloid precursor
protein (APP), a transmembrane protein whose cleavage may result in the formation of βamyloid plaques in the brain. Notch-1 and APP are widely studied proteins that have substantial
impacts on the development and proliferation of cancer and Alzheimer’s disease, respectively.
Notch-1 partakes in the signaling of apoptosis in damaged and mutated cells, thus its cleavage by
γ-secretase within the plasma membrane has ramifications on cell growth and proliferation.
However, the APP molecule is the key protein in the metabolic pathway that produces small
amyloid fragments. These fragments, in undesirable conditions, have the propensity to aggregate
and form, as stated above, amyloid plaques, depending on the fragment length. These plaques
have been long believed to inhibit neuronal function if they are not degraded or removed from
the intracellular space, specifically in the brain.
Due to these widespread mental and physical health impacts, isolation and modulation of
the cleavage of such proteins in intact, controlled bilayers in a highly reproducible, and
potentially high-throughput, process is a key goal in understanding these and a vast array of
intramembrane proteases for the development of pharmaceutical therapies. The work presented
looks to the development of one such platform, yielding crucial spatial and temporal information
within these complex lipid microenvironments. Synthetic, biomimetic membranes were studied
and manipulated to develop biologically relevant systems in which to resuspend isolated
proteins. A formulation of sphingomyelin, 1,2-Dioleoyl-sn-phosphatidylcholine (DOPC), and
cholesterol was chosen due to its attributes in resembling fundamental lipodomics within a
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human brain cell. It is shown that this canonical formulation and subsequent formulations with
added complex mixtures, yield a lipid system that retains visible phase separation to a
quantifiable degree. These lipid formulations, when fused with solid silica support structures
such as planar surfaces or silica microbeads, allows for the reconstitution of the three of proteins
of interest.
These assay and high throughput platforms are essential to understanding key functions
and potential modulations of these protein pathways, however this approach does not fully
replicate the biological environment these proteins experience within an active cell. Two
approaches are shown in this work to increase the biological relevancy of these platforms.
Tethering of the solid support structures with a series of polyethylene glycol (PEG) polymers
culminating in a functionalized capping moiety that can yield overall increases to protein
mobility, and added functionality of the platform. Additionally, added dopants of more complex
lipid components into the basic lipid membrane analogue shows the ability to increase
complexity of the formulation and closes the gap between the synthetic membrane and the
protein’s true biological lipid environment.
These platforms are highly robust and rugged in nature and lend themselves to be useful
in future high-throughput screening and functional assay processes in pharmaceutical research.
The coupling of both planar surface support structures and micro bead structures in tandem can
be analyzed through confocal, super-resolution, and atomic force microscopy, leading to a fuller
understanding of these complex spatial reaction-diffusion systems prevalent within human cells.
The systems developed in this research, apart from being tested with the aforementioned
proteins, are not protein-specific and thus could yield a viable platform on which to test any
number of isolated transmembrane proteins in a highly reproducible manner.
v

Preface
The intent of this thesis is to develop and expand the field of potential viable protein
assay and analysis platforms due to their large potential as drug and therapy targets in the
pharmaceutical industry. The experiments chosen in this work were chosen to exemplify the
utility and potential uses of in tandem studies performed on both planar supported bilayers and
proteolipobead constructs, as well as the use of atomic force microscopy and confocal
microscopy to yield a well-defined and characterized, and modular high-throughput solution for
further protein analysis. A major theme of the work presented throughout this research is the
flexibility of a modular approach, developing base systems that can be made more complex or
more functional at the future researcher’s behest. Flexibility in these systems yields a wider
impact potential on the viability and function as a protein analysis platform.
Chapter 1 begins by introducing the systems and platforms developed over the course of
this study, and the biological relevancy and importance of the specific proteins analyzed in this
work. The focus here being to elucidate the approach to developing biologically relevant assay
and analysis platforms which can be used in high-throughput screening testing to better
understand the intricacies and functions of these proteins. The methods of characterization and
study used in this work are introduced to lay the foundation on which the claims in the results
and conclusions are developed.
Chapter 2 provides the approach and modifications developed on the basis of a
canonically used lipid membrane formulation for the study of proteins in supported lipid
bilayers, both on planar supports and microbead systems. Sphingomyelin (SM), 1,2-Dioleoylsn-glycero-3-phosphocholine (DOPC), and Cholesterol are combined here to for a well-studied
vi

brain cell membrane analogue. This analogue, while useful, still lacks in fully capturing the
cellular lipid environment, and thus more complex mixtures and dopants were added to increase
the system’s overall biological relevance. Chapter 3 is the core protein work of this research.
This chapter gives the account of using these biologically analogous lipid formulation in order to
develop and express γ-secretase and two of its known substrates, derived from Notch-1 and the
Amyloid precursor protein. These three proteins are shown to be reconstituted in both the planar
supported bilayer, as well as the lipobeads construct yielding a tandem approach to
characterization, functional assays, and high-throughput analysis and testing.
Chapter 4 presents the work performed in developing functional polymers tethering
supports structures on the surface of the solid support structures. By using a series of relatively
simple ester-linkage chemistries, a solid surface can be fully coated with a modular polymer
support structure to help provide further functionality in assays and analysis of these biomimetic
systems as well develop a system that more closely resembles the mechanical properties of the
biological environment which is trying to be mimicked. The process shown here is
straightforward and modular in an attempt to create a basis for a system that can afford a host of
functionalities rather than one static system.
Finally, the overall conclusion and claims made in this work are summarized in chapter 5
along with any future works possible to further ratify claims or answer questions raised by this
research.
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Chapter 1. Introduction
I. Motivation
High throughput screening has become a staple in the study of chemical therapeutics and
pharmacology[1]–[3]. This is a process by which large quantities of chemical species are tested
for their efficacy in order to eliminate species with low efficiency or some level of toxicity, as
these characteristics make for a poor therapeutic or commercial drug. High throughput screening
is an ideal technology for the drug and pharmaceutical industry, as it allows for high volume
testing, for low effective cost, and it simultaneously eliminates the need to further study
compounds with little to no efficacy and push them through costly FDA approval trials.[4], [5]
Microbead and particle-based high throughput screening has gained a prominent foothold within
this field, as to harness the power of flow cytometry[6].
Transmembrane proteins are currently a class of proteins with which high throughput
screening techniques have only been used for approximately 10-15 years. These proteins are
difficult to isolate and test while maintaining similar levels of functionality as found in cell
studies. The main difficulty with this category of protein arises from its necessity to be
suspended within a cell membrane, due to its amino acid structure creating a sizeable
hydrophobic domain, which in cells sits within the confines of the plasma membrane. Cell
studies are time and money intensive due to the necessary genetic modifications required to
isolate and explore singular protein pathways, however this is the most common screening
method for transmembrane proteins at the present.
It is thus desirable to develop a platform on which transmembrane proteins can be
reconstituted, while maintaining cellular levels of functionality in a highly controlled and
1

reproducible manner. Under these constraints, a process has been developed to engineer
synthetic plasma membranes, fuse them to solid support structures, and reconstitute a
transmembrane protein known as γ-secretase into these membranes along with two of is
substrates in order to test key metrics that associate with function in in vivo studies[7]. Namely
these metrics include lipid microenvironment, diffusion, partitioning, and enzyme activity.
II. Plasma Membranes
The study of plasma membranes, or lipid bilayer, has been an ongoing pursuit for many
generations [8]. A lipid bilayer is formed when molecules with a hydrophilic head group
attached to a hydrophobic tail, known as a lipid, begin to self-assemble in aqueous solutions as a
way to minimize their free energy. The lipids self-assemble into double sided sheets with the
hydrophobic tails towards the center and the hydrophilic head groups jutting out into the water,
called lamella.
Since the identification of the cell and its constituents, lipid bilayers have been known to
play an important role in many biological functions with the main functional unit arising in the
form of the cell membrane. The cell membrane is considered to be a fluid mosaic [9]. This
means that while it can be considered a solid barrier for some large molecules, it is actually
mobile and comprised of numerous mobile moieties including, proteins, lipids, and sugar[10],
[11]. These mobile units give the membrane its structure and function creating highly complex
intertwining networks which are the root of various cell processes. It is this quality of the cell
membrane which makes it an interesting topic of study.
In recent year, the hypothesis of lipid raft formation has been a hotly debated topic
between lipid membrane researchers[9], [12], [13]. The lipid raft theory states that small,
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sometimes nano-scale gradients of lipid species occur throughout the confluent bilayer of the
plasma membrane, and that these spatial gradients are an active player in cellular dynamics[14]–
[16]. Recent studied into cell lipid fractions using lysed cells dissolved in detergent show that
two regimes exist within cell plasma membranes, a more rigid and viscous regime, known as the
liquid ordered domain, and a less detergent resistant, more mobile, liquid disordered domain[17].
This work was further confirmed through the use of NMR, as these studies are what gave rise to
the distinction of the liquid ordered versus disordered phase as the order and disorder are a
reference to lipid acyl chain order parameters of lipids within the phases[18]–[20]. These
cholesterol-rich microdomain are thought to be thicker and more viscous than the liquid
disordered phase[21]–[23]. Cellular lipodomics reveal a multitude of lipids present in the entire
cellular lipid biome, reaching levels of 10,000+ individual species within a single cell[24]. This
large array of lipids found in the cellular biome makes the domain structure practically
unresolvable under most common imaging methodologies.
Synthetic lipid bilayers have been developed in various forms as a stable yet dynamic
system for understanding some high level cellular functionality like cell to cell interactions,
integral membrane protein function, and microenvironment changes [25]–[28]. A large push in
the study of lipid bilayers is in the form of studying giant unilamellar vesicles (GUVs), giant
plasma membrane vesicles (GPMVs), and proteoliposomes [29]–[34]. These systems are widely
used due to their ease of formation, and are helped by the fact that GUVs and GPMVs are easy to
image due to their large size. However, they have some drawbacks when it comes to their
versatility in experimentation as these systems are not very robust as a testing platform due to
their susceptibility to puncture, cavitation, and inherently have no support structure. Due to the

3

lack of support, a new platform was developed to create a more robust system that resists
deformation while maintaining native levels of bilayer fluidity.
Supported lipid bilayers have been used as membrane mimics for a handful of years now
[35]–[37]. The most common form of supported lipid bilayer is the planar bilayer, which is
created through one of two procedures. The first method is through the use of a LangmuirBlodgett trough, when a hydrophilic material is coated with the lipids a single layer at a
time[38]–[40]. The Langmuir Blodgett approach allows for an added level of control over each
layer deposited onto the hydrophilic surface, and this control has the potential to form
asymmetric lipid bilayers. Asymmetric lipid bilayers, commonly found in biological systems,
are bilayers forced into a state of non-equilibrium in which each leaflet of the bilayer has a
varying composition of lipids[41]–[44]. Asymmetric bilayers are difficult to maintain in situ as
most supported lipid systems tend towards an equilibrium between both leaflets of the bilayer as
well as all molecular species within the bilayer.
The more common method is through lipid vesicle adsorption onto the hydrophilic
surface, in which a suspension containing unilamellar vesicles is exposed to the hydrophilic
surface for a desired time[45]–[48]. The vesicles deform and rupture on the hydrophobic surface
and reform into a confluent lipid bilayer. Planar bilayers are useful for the study of many
systems due to the rigidity of the material and the ability to deposit the bilayer directly onto a
microscope glass slide or coverslip. Secondly, the planar hydrophobic surface affords the added
ability to functionalize and augment parts or all of the solid surface, giving rise to added levels of
control and versatility in the lipid platform[46], [49].
There is a drawback to these planar supported lipid bilayers in the characteristic that these
platforms are two dimensional. In some cases a three dimensional approach is beneficial as it
4

allows for a more precise mimic of the biological system in the case of cellular interactions with
these types of platforms. To this end, a three dimensional platform has been developed in the
form of a spherical bead which is used as the solid support for the lipid bilayer. This lipobeads
(LB) is a lipid bilayer suspended on the surface of a hydrophilic surface much in the same way as
the planar bilayer is suspended in the planar bilayer system[50]–[53]. The LBs can be formed
through normal adsorption of vesicles onto the surface, or through a Langmuir Blodgett approach
as well. The beads, much like the hydrophilic surface in the planar system, can also be
functionalized to yield a higher level of control and versatility to the 3D platform, including
integrating wash steps to remove excess membrane proteins and lipids that could give artifacts.
Furthermore, this format is amenable to flow cytometric analysis and screening.
III. Transmembrane proteins
Soluble and transmembrane proteins make up 2-4 million molecules per cubic micron of
the mammalian cell, and a large subspecies of these proteins are integral, or transmembrane
proteins (TMPs) [54], [55]. These proteins span the width of the plasma membranes within cells
and perform many tasks ranging from transport, to cell signaling, as well as housekeeping
functions. Many of the larger protein structures such as aquaporin, an integral membrane protein
which allows for a large flux of water to travel through the membrane, have been studied intently
over the years [56]. Though, this work only scratches the surface of the entire class of TMPs
available for study as these proteins are difficult to study and understand due to their complex
nature and steep requirement for a fluid bilayer to remain functionally viable. Most integral
membrane proteins lose functionality when removed from the confines of a lipid bilayer, also
aggregation of hydrophobic domains and denaturation occurs with these proteins when they are
no longer stabilized by a confluent lipid bilayer or by detergents. It has also been shown that the
5

surrounding environment has effects on protein function, the environmental effects could be due
to a global effect of the homeostasis of the biological system or could arise from small micro or
nano environmental changes within the lipid bilayer, such as lipid bilayer thickness changes and
raft formation or dissipation[57]–[59]. In systems comprised of multiple protein interactions and
pathway triggers, orientation of the protein within the bilayer is another important factor which
can confound the study of these proteins outside of the cell structure. As in cells, this expression
and insertion into the cell membranes is facilitated through a series of chaperone proteins helping
during transcription.
Current TMP studies rely heavily on recombinant cell and bacterial culture studies, in
which eukaryotic or prokaryotic cells are genetically modified to over express these proteins or
to suppress the expression of other proteins in order to isolate a single TMP system. These
studies are long, difficult, and expensive while also plagued with a sense of uncertainty[60]–[63].
Cell and bacterial cultures are incredibly dynamic and complex systems which are still not yet
fully understood in some cases [64]. Many metabolic and signaling pathways have not been
completely mapped as of this time, while other pathways which are understood have multiple
levels of redundancies built into them in order to maintain cell viability in the absence of a
molecular pathway [65]. These built in redundancies and failsafe pathways have been developed
over hundreds of thousands of years of evolution in some cases and are thus very hard to account
for in these types of assays.
A desirable assay for integral membrane protein study must include the ability to isolate
the interesting proteins and its substrates, proper environmental control of the lipid or
homeostatic system, and proper orientation control of the protein in native cellular formats.
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IV. Gamma Secretase and its Substrates
A subset of these integral membrane proteins is a class of cleavage enzymes known as
intramembrane proteases, and one in particular is of paramount interest. γ-secretase is a cleavage
enzyme found throughout mammalian biological systems, it is a protease which cleaves other
TMPs at an active site located within the hydrophobic domain of the lipid bilayer shown in
figure 1.1.[66] There are two proteins of interest which this enzyme is known to cleave, one
being the amyloid precursor protein (APP) and the second being the protein Notch-1 shown in
figure 1.2. Both of these substrates are interesting because they are believed to hold a role in the
development of Alzheimer’s disease and the proliferation of cancer cells, respectively [67], [68].
γ-secretase is a large integral membrane protein on the order of 170 kDa, with multiple
transmembrane helixes and extracellular domains. -Secretase is an enzymatic complex
composed of at least four proteins: presenilin 1 or presenilin 2 (PS1 or PS2), Nicastrin, Pen2 and
Aph1, with presenilin representing the catalytic core. In 2015, a 3.4 Angstrom resolution cryoEM structure of the enzyme was obtained, and further structures have been obtained showing the
protein in an active configuration[69]–[72]. This discovery has given insight into the function
and processes of this enzyme, but native configuration testing has not yet been completed.

Figure 1.1 γ-secretase structure and domain distribution. This is a representation of the full γsecretase structure as seen in the PDB file 5a63. Panel A Shows the γ-secretase protein positioned within
a confluent lipid bilayer. In panel B the γ-secretase molecule is colored to represent the different charge,
hydrophilic, and hydrophobic domains. Panel C displays the isolated γ-secretase shown here exposing the
sizeable hydrophobic domain displayed in white.
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Figure 1.2 APP and Notch-1 substrate structures. Panel A here is a truncated structure of the APP
known as C99 (PDB: 2LP1) as it is 99 amino acid residues long. The arrow here indicates the cholesterol
binding domain found in the APP structure which is suggested to effect partitioning and diffusion of the
protein. Panel B shows the Noth-1 signaling protein structure (PDB: 5KZO)

The APP substrate is cleaved by γ-secretase within the cell membrane, but the cleavage
specificity and efficiency are unknown outside of the fact that this cleavage can create 2 distinct
byproducts and the productions of these fragments can be correlated to cholesterol content [73]–
[75]. One byproduct of this cleavage is a harmless protein fragment which can be further
digested and recycled into the cell, while the second possible byproduct is the formation of an
amylogenic protein fragment which cannot be further digested by the cell or other biological
enzymes. This second amylogenic protein has the propensity to form amyloid aggregates which
can grow into amyloid plaques[76]–[78]. Amyloid plaques that form in the brain can disrupt
neuronal function and health, resulting in the possible development of neurodegenerative
diseases such as Alzheimer’s, dementia, and potentially many others. These different byproducts
are a result of a switch in cleavage position along the peptide strand, called cleavage specificity.
The efficiency of γ-secretase is related to the enzymatic rate of the cleavage. As stated above, it
has been shown that cholesterol plays a significant role in determining the cleavage specificity of
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γ-secretase, though it is unknown whether this effect is due to a global increase of cellular
cholesterol concentration or micro/nano environmental effects which arise from a higher
concentration of cholesterol in the lipid bilayer.
Notch-1 Is a cell signaling protein [68], [79], [80]. Notch proteins are well known to
contribute to cell proliferation, differentiation, and apoptosis. Healthy cells express an activated
form of Notch-1, it is believed that γ-secretase cleavage is the activation step of the Notch-1
protein. When γ-secretase is blocked, Notch-1 cleavage and activation also becomes blocked
causing the cell to signal for apoptosis. When healthy cells are damaged or begin to function
improperly, signals are released which block the enzymatic capabilities of γ-secretase, thus
causing a cascade effect leading to the destruction and apoptosis of the unhealthy cell. It has
been shown however that in some cancerous cells, these damage signals are suppressed and thus
γ-secretase continues to activate Notch-1 as it would during healthy cell function. This leads to
the proliferation of cancerous cells in the body and potential tumorigenesis[73], [81], [82].
Understanding the function and enzymatic rate of γ-secretase and its substrates in these
two systems could hold the key to a fuller understanding of these diseases and potential
therapies.
V. Microscopy
Light microscopy is a well-defined and widely used experimental tool[83]. A key feature
of light microscopy is the idea of fluorescence microscopy. Fluorescent molecules are molecules
that can absorb the energy of certain wavelengths of light, this absorption is used as energy to
cause electronic transitions between energy levels within the molecular structure. This excited
electron state only lasts a brief period of time however, and when the system returns to ground
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state, the energy release by the system has been diminished slightly and is released as a red
shifted photon. This means a fluorescent molecule can absorb light at one wavelength and emit
light at a longer, lower energy wavelength. Light microscopy and fluorescence can be used in
conjunction in another imaging technique named confocal scanning light microscopy
(CSLM)[84], [85]. This imaging modality was developed as a method to visualize 3D structures
from a 2D imaging modality. CLSM uses a double pinhole set up in which the position of the
pinholes can be tuned in such a way that the photon detector only captures light from a specified
focal plane through the sample at a specific voxel. A series of images can be taken by adjusting
the pinholes to focus on discreet neighboring focal planes, then the images can be combined with
computer software to produce a 3D image of the sample[86].
Light and confocal microscopy have been used extensively as an imaging modality in
biological systems since light microscopy is one of the few methods which does not require
sample fixation, and can be performed on a live cellular sample. With the correct choice of
fluorophores, the entire internal structure can be viewed in real time, and with this method, real
time assays can be performed on active systems. The correct choice of fluorophores is an
important aspect of fluorescence microscopy ever since the development of the Forster resonance
energy transfer (FRET) technique of imaging [87], [88]. FRET is the process by which a single
fluorophore, is raised to the excited state but rather than release this energy as a photon, the
donor fluorophore pairs with an acceptor within a threshold distance and undergoes an energy
transfer due to a resonant coupling. The second fluorophore then relaxes to ground state,
releasing a photon of light[88]. This transfer of energy not only occurs between two
fluorophores whose emission and excitation overlap, but it also only occurs when these two
fluorophores are within a specific distance from one another. The intensity of the emitted light
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from the second fluorophore can be used to calculate the distance between the donor and
acceptor at the time of imaging. This technique has helped understand the spatial separation of
molecules and biological moieties in countless studies[88]–[94].
Biological systems are difficult to study in other forms of microscopy such as electron
microscopy as the bombardment of the sample with a high powered electron beam causes serious
damage to live cells and in some cases cannot even be performed on live samples. Yet this
imaging modality comes at a cost of resolution. Light microscopy uses light in the visible, and
near visible, spectrum in order to create images, and thus the possible resolution of these images
is handcuffed to the wavelength of visible light. The resolution of images taken with light
microscopy is on the order of >200 nanometers, while electron microscopy can reach resolution
limits of <2 nanometers. As stated above, cellular structures and membrane domains can be on
the order of 1-2 nanometers, and the lipid bilayer itself is approximately 4 nanometers thick
depending on lipid composition. Light microscopy is limited by Abbe’s diffraction limitation
which is shown in equation 1, meaning that resolution is directly proportional to wavelength of
light detected and the limits of the mechanical system (numerical aperture, refractive index, etc.).

𝑑=

𝜆
[1]
2 ∗ 𝑛 ∗ sin(𝛼)

In the past 5 years, new imaging modalities have emerged within light microscopy. In
2014, Stefan Hell, Eric Bertzig, and William Moerner won the Nobel Prize in chemistry for the
development of a light based imaging technique which breaks the law of Abbe’s diffraction
limitation, and their work in single molecule microscopy. This imaging technique is called
STimulated Emission Depletion (STED)[95]–[97]. This new technology uses a 2 beam system in
which the excitation light travels through the sample as normal, while a second wavelength of
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light, tuned to emission spectra of the imaged fluorophore is modulated as a ring around the
excitation beam. This depletion “donut” quenches all of the fluorescence caught within the ring,
and thus only a small focal point emits any light to the detector. Through this method of
imaging, the resolution limit of light microscopy is able to reach approximately 50 nm, a shift of
about one order of magnitude greater resolution in live systems[96]. However, this method
cannot be ubiquitously implemented as the fluorophores applicable to this modality are limited
and specific.
Similarly in 2014 a second approach to this question of super resolution light microscopy
was developed and implemented by Zeiss[98], [99]. This procedure was named Airyscan, and
this modality to super resolution yields resolutions of 140 nm laterally and 400nm axially, about
2-3 times less specific than the STED, but the Airyscan method is not restrictive in usable
fluorophores[100]. The Airyscan method consists of using an array of pinholes in lieu of a
single pinhole for imaging. This array allows for the detection of particle “movement” as a
function of the laser scanning aspect of confocal, where the object does not move but rather the
moving laser light during the scan illuminates the fluorophore in a quantifiably different
orientation during the course of the scan. Due to the location and layout of the pinhole array, this
allows for the reflected light to only pass through certain pinholes depending on the orientation
of the laser illumination which allows for a recombination of the pinholes images to produce a
super resolution image.
The final approach to microscopy for this work is Atomic Force Microscopy
(AFM)[101]–[103]. AFM is an experimental modality with a variety of potential uses. A small
functional probe is positioned to reflect a laser light onto a specialized detector, modulations in
the probe tip cause the laser reflection to move along the detector and this movement is
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quantifiable as a deflection from a normalized position. Understanding and testing the material
characteristics and shape of the AFM probe tip allows for a variety of calculations to be made
about the sample being tested. Attractive, repulsive, indentation, and extraction forces can be
obtained from samples through the use of force curves. AFM also allows for the development of
an effective image of the sample being tested. AFM tapping or constant contact mode both
produce a type of image over a small scanned area. By measuring the probe tip deflection over a
small area, an effective 2D height analysis image can be developed. These images have a
relative resolution limit below 1 nm. This resolution limit is effected by the shape and design of
the probe tip, and the accuracy of the photodiode detector.
A combination of the aforementioned microscopy modalities can be used in tandem in
order to develop nano and micron scale characterizations of samples and platforms described
herein.
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VI. Tables
Table 1.1. List of Materials and Molecular structures.
Materials
Name

Atomic Structure

Cholesterol

Properties
Sterol molecule
used in all sample
formulations

Brain Polar Lipid Extract
(BPLE)

N/A

L-α-Phosphatidylcholine (PC)

lipids extract used
as majority
component of
biomimetic
system
Purified lipid used
in the biomimetic
system

Sphingomyelin (SM)

Liquid ordered
mimic lipid used
in minimalist
formulation

1,2-dioleoyl-sn-glycero-3phosphocholine (DOPC)

liquid disordered
mimic lipid used
in minimalist
formulation

1,2-distearoyl-sn-glycero-3phosphocholine (DSPC)

long chain
saturated lipid
molecule for use
in cancer lipidome
tests

1,2-dipalmitoyl-sn-glycero-3phosphocholine (DPPC)

long chain
saturated lipid
molecule for use
in cancer lipidome
tests

14

3,3'Dihexadecyloxacarbocyanine
Perchlorate (DiO)

Lipophilic
fluorescent tracer.
Excitation/Emissi
on: 488/506

1,1'-Dihexadecyl-3,3,3',3'Tetramethylindocarbocyanine
Perchlorate (DiI)

Lipophilic
fluorescent tracer.
Excitation/Emissi
on: 551/570

Streptavidin-AlexaFluor 660
(SA660)

N/A

(3Aminopropyl)trimethoxysilane(
APS)

Protein
fluorescent tag.
Excitation/Emissi
on: 660/690
amino silane used
in silica
modification

bis(sulfosuccinimidyl)suberate
(BS3)

zero-length cross
linker

Polyethylene Glycol (PEG)

Polymer spacer

N-hydroxysuccinimide- PEG4Biotin (NHS-PEG4-Biotin)

tethering moiety/
streptavidin
functionalization

N-hydroxysuccinimide- PEG41, 2 Distearoyl-sn-glycero-3Phosphoethanolimine (NHSPEG4-DSPE)

tethering
moiety/lipid film
anchor
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Chapter 2: Sphingomyelin/ 1, 2-Dioleoyl-sn-glycero-3-phosphocholine/
Cholesterol Formulation and variants
I. Introduction
This chapter focuses on the development and optimization of the synthetic lipid analogue
environment built for control and reproducibility. This work focuses on a widely used and
studied SM/DOPC/Cholesterol system, which has been used as a mimic for the lipid
environment of a brain cell. It is shown here that synthetic lipid membranes are producible across
a wide variety of components and molecules. These lipid formulations can be used as
representative analogues of all possible cell and organelle membranes to further increase the
biological relevancy of these lipid microenvironments. It is shown here that reproducible
membranes with visibly quantifiable characteristics can be formed through a straightforward
process of dissolution, mixing and drying to form starting materials for supported lipid bilayers
on particles or surfaces.
II. Materials and Methods
Purified Sphingomyelin (SM), DOPC, cholesterol, Brain polar lipid extract (BPLE), 1,2Distearoyl-sn-glycero-3-phosphocholine (DSPC), 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine
(DPPC), and L-α-phosphocoline (LPC) were purchased from Avanti Polar lipids in powdered
form. Fluorescent lipophilic tracers DiO, DiI, and Perylene were purchased from Molecular
Probes, and added at 0.2%, 0.2%, and 0.4% (molar or weight equivalence as shown in Table 2.1)
respectively in the lipid films in which they were used. Chloroform 99.9%, extra dry was
purchased from Fischer-Scientific.
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Lipid films were created by dissolving the purified lipids and lipophilic tracers in
chloroform and then combining them to a total weight of 4 mg of total lipid and desired
concentrations within 4 ml amber glass vials. These mixtures, shown below in table 2.1 were
then dried in a vacuum chamber overnight (minimum of 8 hours) protected from light to help
preserve the fluorescence of the lipophilic tracers. This process removes the chloroform from
the mixture while leaving a deposition of the lipids in the glass vial, thus a film. After drying,
any unused stock solutions or films to be stored were placed in a positive pressure chamber and
flushed with inert gas, sealed tightly in parafilm, and placed in desiccated jars in the freezer at 20°C. Any films prepared for immediate use were removed from the vacuum chamber and
rehydrated with 2 mL of PBS.
The films, upon rehydration, were mixed vigorously using hand mixing and a vortex
mixer to ensure that all deposited lipid was suspended into the PBS aqueous phase. The
rehydrated multilamellar vesicle (MLV) solution was then transferred from the amber glass vial
into a 15 mL conical tube and placed into a 37°C water bath. Allowing approximately 5 minutes
for temperature equilibration, the MLV solution was then sonicated for 15 minutes in a
BioLogics Inc. 150 V/T Ultrasonic Homogenizer. This sonication produces a solution of small
unilamellar vesicles (SUV) liposomes of relatively uniform size. After sonication, the liposomal
solution is placed in an Emerson centrifuge and spun at 1500 rpm for 2 minutes to remove any
debris accumulated throughout the previous steps. The supernatant is then transferred to a fresh
15 mL conical tube. 500µL of the liposomal solution is taken from the newly centrifuged tube
and placed in a 1.5 ml microcentrifuge tube. This microcentrifuge tube is then replaced back
into the 37°C water bath to once again equilibrate, approximately 5 minutes. These liposomes are
then used further for varying liposomal fusion studies.
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Separately to the formation of lipid films and SUV solutions, glass surfaces and 5 um
silica beads were prepped for lipid fusion. Glass slides, coverslips, and silicon dioxide chips
were cleaned overnight in Piranha solution, the supports were then washed thoroughly with DI
water. Piranha solution was made as a mixture of Sulfuric acid and Nochromix, (Fischer
Scientific) at a ratio of 1 g of Nochromix for every 100 mL of sulfuric acid. To ensure the glass
surfaces were free of piranha solution and any excess sulfuric acid, the washing was performed
by submerging the glass support in pure DI water in an ultrasonic cleaning bath (Branson B1510
Ultrasonic Cleaner) for 15 minutes, followed by a series of dunk washes in fresh DI water, and
finally dried using compressed inert gas. The 5 um silica beads (Bangs) were weighed out and
mixed to a total concentration of 1 mg of beads per 1 mL of PBS in a 15 mL conical tube. This
mixture was then placed in a bath sonication unit (Branson) for a minimum of 15 minutes, to
break apart any microbeads that may have stuck together upon shipping and dry storage. After
sonication, an aliquot of the microbead solution was then placed into a 1.5 mL microcentrifuge
tube and placed in the 37°C water bath until fusion.
After the SUV solution, the microbead, and glass surfaces have been prepped, then the
liposomal solution is fused to the solid support structures. To undergo fusion of the SUVs to the
microbeads, 200 µL of the heated microbead suspension is pipetted dropwise into the 500 µL of
SUV liposome solution. After dropwise addition, the new mixture is lightly hand shaken, briefly
mixed on the vortex mixer, and then placed in an end-over-end rotomixer located within a
repurposed cell incubation chamber held at a constant 37°C. This fusion was completed at 3
separate timed intervals, 30 minutes, 18 hours, and 24 hours. After these times have been met,
the fused lipobeads solutions were spun down in a microcentrifuge, the unfused liposomal
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supernatant was removed and replaced with fresh PBS, and then the pellet was then resuspended,
this process was repeated 3 times.
To fuse the liposomal solution onto the planar glass surfaces, the heated liposomal
solution was pipetted onto the clean glass and then placed into the above mentioned incubation
chamber for 30 minutes. The glass surfaces were then removed from the chamber and washed.
There were three approaches to washing due to the intricacy and care needed to not shear off any
of the fused lipid bilayer from the bare glass surface. The first approach was a series of
immersion in a petri dish filled with fresh PBS, after the immersion, the glass surface was gently
removed from the petri dish, the contents of the dish were discarded and the surface was
immersed again, repeated for a total of 3 washes. The second approach was to pipette off the any
excess liquid, leaving enough to just cover the extents of the fused area, then looping a small
piece of parafilm around the opening of the pipette and adding fresh PBS back onto the surface.
The parafilm was used to limit the shear force of the PBS leaving the pipette tip and dampen it
over a broader area to minimize any bilayer disruption. This process was once again repeated
thrice. The final technique was to remove any excess liposomal solution, similar to the second
technique, however in the samples prepared with this technique the sample area to be imaged or
tested was demarcated on the glass surface, so the fresh PBS was pipetted outside of this
demarcated and the natural spreading and surface tension of the PBS was used to wet the surface.
This process was performed 3 times, like all other samples, to insure them removal of any excess
unfused SUVs from the final sample.
These samples were then imaged using both CLSM and AFM modalities. The confocal
images were obtained by excitation of the DiO and DiI probes with a 488nm laser, this laser
would excite the DiO molecule which would then undergo FRET with the DiI probe, which
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would then emit light between 550-600 nm collected by the detector, any light emitted by the
DiO probe was collected between 500-549 nm. CLSM imaging was also coupled with 2 super
resolution techniques, the first being STimulated Emission Depletion (STED) from Leica and the
second being Airyscan from Zeiss. STED microscopy was performed for the DiI and DiO
samples using an excitation beam of 488 nm, and a depletion laser of 592 and 660 nm in varying
tests. The Airyscan images were obtained using a 488 nm excitation beam and the same 2
detection windows as stated in the base CLSM studies.
III. Results and Discussion
Throughout these tests a main staple of the experimental set up was the use of the DiO,
donor, and DiI, acceptor, FRET method described in Baird et.al[88]. This method is a very
powerful way to isolate out and quantify the apparent phase partitioning within our lipid systems.
DiO and DiI do not fluoresce in solution, so there was no worry of any background excitation,
and so the only source of emitted light would be from a lipid bilayer, on top of this fact the
FRET technique yielded a secondary level of clarification and further delineation of the two
phases believed to be present in these samples. Figure 2.1 shows the comparison between
samples containing no tracer, acceptor only (DiI), donor only (DiO), and with both dyes present.
It is visible that under acceptor only conditions, the DiI signal is weakly visible throughout the
lipobeads while illuminated at 488 nm. In the donor only condition, the DiO signal is visible
throughout the entire lipobead and shows a small, negligible amount of bleed through into the
higher wavelength detection channel. However it is seen when the samples contain both DiO
donor and DiI acceptor the lipobead yields bright signal in both channels, and in this case the
DiO signal is slightly weaker than in the donor only case due to the FRET phenomenon. These
two lipophilic probes have been shown to have an innate preference of one lipid phase over
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another, this was a point of contention once or twice throughout all of these studies, and this
preference is a tendency to partition into the Ld phase of the bilayer.

Figure 2.1 FRET dye pair validation. This chart shows the use of the FRET fluorophore labeling
structure. All lipobeads were illuminated with a 488nm laser and the detected emission windows are
shown on the left. All of the lipobeads images have their intensities normalized. In samples containing
neither the DiI nor the DiO probe, no emitted light is seen in either window. In samples containing
strictly the DiI fluorophore, the fluorophore is shown to emit a very low and weak signal barely above the
overall noise level of the samples. The samples containing only the DiO lipid show a very bright
emission in the expected DiO detection range with a small amount of bleed through into the DiI detection
window. Finally, samples containing both the DiI and DiO lipid show bright signal in both detection
windows, however the signal seen in the DiO detection window is slightly dimmer than in the samples
containing only DiO, this is due to the FRET phenomenon in which a large number of DiO molecules will
not emit excess energy as light but transfer it to the DiI fluorophore.

Initial tests were performed on two systems to verify the existence of visual phase
separation. Previous work had shown a system containing BPLE, LPC, and Cholesterol would
yield a confluent lipid membrane for use in lipobeads systems, and maintained activity of key
TMPs, most importantly γ-secretase. However, one drawbacks of this lipid system was the
inability to discern lipid phases and thus lacked important spatial and microenvironmental
information which was a desired trait, of the γ-secretase system, to study. BPLE is a desirable
component for use in a synthetic mimic of a brain cell microenvironment due to the fact that it is
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a total extract of lipid material from lysed brain cells, which affords any brain cell TMPs a more
biologically relevant microenvironment.
Figure 2.2 shows the comparison of lipobeads of the SM:DOPC:cholesterol
formulations(2.2 A, B) to those composed of the BPLE:LPC:cholesterol (2.2 B, C) lipid
formulation. The fluorescent spectral scans in panels B and D shows that both of the lipid
formulations contain the DiO donor and DiI acceptor pair of fluorophores, with emission maxim
of 505 nm and 555 nm respectively. Panel B shows the comparative intensities calculated from
the two highlighted inset regions, a readout of the FRET spectral signature of the Lo and Ld
phases. The intensities of the dyes are approximately 4-fold higher in the Ld phase, and the
relative intensity of the donor to acceptor decreases in the less concentrated Lo phase, indicative
of a change in FRET efficiency.
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Figure 2.2 Spectral comparison of simplified analogue versus biological membrane. A) Synthetic
SM:DOPC membranes shown here with visual phase separation were spectrally imaged, the insets show
the equatorial z section lambda scan from isolated beads from the indicated ROIs to elucidate the intensity
difference in emission intensities between the Lo and Ld phases. Panel B shows the comparative
intensities calculated from the two highlighted inset regions a readout of the FRET spectral signature of
the Lo and Ld phases. Panel C shows A BPLE:LPC lipid bilayer formulation here shows no visible signs
of phase separation and shows high levels of FRET intensity. Panel D displays graph showing the
spectrum obtained from the BPLE:LPC lipid formulation as well as a comparative spectrum from a
SM:DOPC lipid formulation which contained only the acceptor (DiI) fluorophore of the FRET pair.
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The BPLE containing lipobeads in figure 2.2 C have a distinct lack of any visual phase
separation at this resolution. Panel D displays a graph showing the spectrum obtained from the
BPLE:LPC lipid formulation as well as comparative spectrum from a SM:DOPC lipid control
formulation which contained only the acceptor (DiI) fluorophore of the FRET pair. It is believed
that phase separation within this system does in fact occur, but that it occurs on a nanoscale
length scale as opposed to the micron scale seen in the SM/DOPC lipid membrane system. This
nanoscale phase separation is well below the resolution limits of light microscopy, even when
factoring newly developed super resolution techniques such as STED and Airyscan. It is also
believed that due to the multitude of varying lipid species in the BPLE membrane, that these
rafts not only are nano-scale but may also be highly transient as it has been shown in previous
work that rafts tend occur along critical points and energetic tie lines within the ternary lipid
phase diagrams. This lack of visual phase separation led to the adoption and prominent use of
the SM:DOPC:cholesterol, or 2/2/1, lipid membrane formulation throughout most of the studies
performed.
A contention over this partitioning arose when reading Feigenson et al.[27], [104] which
described that in synthetic, biomimetic membranes both DiO and DiI partition into the Ld phase
in SM:DOPC:cholesterol, which is the precise system in which the work here is completed. The
Baird et al. paper describes that the DiO and DiI probes are found more commonly in the
detergent resistant, or Lo, phases of cell membranes, since there work was performed in cell
cultures expressing both the DiO and DiI probes. This discrepancy between the two formats and
difference in synthetic versus biological was debated vigorously, but upon further study of our
systems, the DiO and DiI emission showed many more characteristics of presenting in the Ld
phase, similar to the work of Feigenson.
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This preference is a key aspect as to why we chose a 2 probe FRET approach. As stated,
this partitioning of the fluorescent probes is a preference, but it does not eliminate the presence
of the fluorescent probe in the opposite phase, thus making it more difficult to clearly see the
delineation between Lo and Ld phases in the bilayer. With the 2 probe approach, the FRET
readout of the probes means that the donor and acceptor dyes are distributed in the bilayer
together, as this FRET phenomenon only occurs when two probes are approximately between 36 nm apart and is thus proportional to the concentration and therefore the partitioning of the
probes between Lo and Ld phases. This phenomenon limits the amount of signal seen in areas
that are sparsely populated by both fluorophores, and occurs only when a sufficient concentration
exist within the membrane. If both probes have a preference to the Ld phase, and only under
FRET when in close proximity, it is understandable the fluorescence we collect from the
acceptor DiI probe would happen almost exclusively in the Ld phase of the lipid bilayer. While it
is possible to isolate the fluorescent signal of the disordered phase, it leaves the ordered phase to
be imaged by the examination of the lower registers of the detected fluorescence, utilizing the 16
bit depth of the modern confocal microscopes (0-65536 levels for 16 bit versus 0-256 levels for 8
bit detection). This would mean that what is seen in the data collected, is that the areas devoid of
fluorescence on the planar surface or microbead constructs is the Lo phase (shown as false red
color in Figure 2.2 A).
Upon further study of this fluorescent dye system a secondary approach was attempted to
verify the existence of a confluent lipid bilayer, while maintaining the ability to discern visual
phase separation. A third fluorescent probe was added into the lipid film formulation, Perylene.
From Feigenson’s work with fluorophores in lipid systems and its use in the Dimova paper,
which heavily influenced the work performed, it was deemed a viable candidate to help elucidate
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the confluency of the lipid membranes within the lipobeads systems[27], [104]. However Figure
2.3 shows that upon inclusion of this tracer the bilayers lost their visible phase separation
throughout multiple different lipid membrane formulations which had repeated yielded
quantifiable phase separation. Also visible in this figure is the presence of unfused liposomes
containing what appears to be exclusively Perylene signal. The Feigenson and Dimova work
was predominantly performed in giant unilamellar vesicle (GUV) systems, which have vastly
different formation methods than the lipobeads of planar supported bilayer systems in this work.
This difference could be the reason of the discrepancy between their work and the work
performed here, as the fusion process of our planar surfaces and microbead systems is the main
aspect believed to be causing this difference, and this step does not occur in GUV tests.
The fusion step in the samples presented, can cause non-homogeneity to occur within our
samples, a problem that will be addressed later in this work. This lack of homogeneity arises
from the randomness of the fusion process and sonication process within these tests. During the
probe sonication process to produce SUVs which are then used in the fusion step, these SUVs
are created through a series of rapid expansion and compression causing the cavitation and
reformation of larger MLVs into the SUVs used. This cavitation and reformation process is done
through no external control, outside of forcing cavitation, and thus is a pseudo-self-assembly
process which is dictated ultimately by energetics of the system. It makes sense in this case that
if given the size discrepancy and saturation differences of both the DOPC and SM lipids that
reformation would be favorable for vesicles comprised of the same lipids, yielding a potential
range of liposomes from only DOPC to only SM and the gamut in between. Furthermore, we
expect mechanical differences where the more Lo-like liposomes are more rigid and thus would
fuse at lower rates during lipobead formation. This heterogeneity in liposomes for fusion can
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lead to a slight disparity in fusion times required by different liposomes in order to fully coat the
solid support structures. The addition of Perylene into these systems could exacerbate this
heterogeneity leading to an overall increase in the predominance of a single phase, Ld, microbead
fusion. This heterogeneity is likely the cause of the unfused liposome seen in figure 2.3. The
addition of Perylene was eliminated from further studies.

Figure 2.3 Overlay of Perylene and DiI detection in SM:DOPC:cholesterol formulations. A)
Perylene signal obtained by illuminating the sample with a 405 nm wavelength light and detecting at 450480 nm, B) DiI signal obtained by illuminating with 488 nm wavelength laser and detecting at 550-600
nm range. C) Composite overlay of the two showing no apparent phase partition. However, in the
Perylene and composite images small unfused liposomes can be seen attached to the lipobeads and free
floating in the sample. These free liposomes do not show any visible DiI signal, suggesting that they are
predominantly Lo phase liposomes.

The question of confluency is however addressed by the presence of low levels of the
DiO lipid tracer throughout the microbead system. As stated before, the DiO and DiI lipophilic
tracers do not fluoresce in solution, and in all of the solid supported systems, excess and unfused
liposomes other material is washed out from the system over the course of three washes. While
analyzing the microbeads, the ability of the lipophilic tracers to partition into both phases of the
lipid bilayer became a benefit. By increasing the low end intensity of the DiO signal, it becomes
apparent that this signal can be seen surrounding the entirety of the microsphere. This low signal
is above the noise levels inherent in CLSM detectors, and thus signifies the confluency of the
bilayer spanning the entire microbead. This can be checked across all samples, and thus can be
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used to insure proper fusion of the SUV solution onto the solid support systems. Figures 2.4,
2.5, and 2.6 show examples of this analysis across 2 tested samples. Figure 2.4 shows a 2 phase
system in which the phases have each coalesced into separate domains, the average intensity
over the line shows 2 distinct regions in terms of intensity, which are both above background
levels. The region with high intensity is the Ld phase, while the low intensity region is the Lo
phase of the lipid bilayer. Figure 2.5 shows a CLSM image with a similar intensity chart as the
previous figure, however due to the interdigitating of the phase separation regions and the lack of
sub 200 micron resolution, it is difficult to distinctly make out the phase regions, however a
similar trend to what is seen in the previous figure is observable. To further ratify this claim,
figure 2.6 shows an Airyscan image of the same lipobeads observed in figure 2.5, with much
higher resolution and the ability to distinctly observe the intensity difference between the two
phase regions.

Figure 2.4 CLSM general intensity over a domain ripened lipobead. As shown, a DiO fluorophore
intensity was obtained for the bisecting line through a hemispherical projection of a domain ripened
lipobead. The intensity can be seen to have roughly 2 intensity regimes which correspond to the Ld phase
shown as the higher intensity or top portion of the lipobead, and a less intense Lo phase shown as the
bottom portion of the lipobead.
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Figure 2.5 CLSM general intensity over a representative bead. Shown here is the DiO fluorophore
intensity obtained along the line bisecting the hemispherical projection of a single representative bead.
The intensity levels fluctuate over the entirety of the bead and due to resolution limitations it is difficult to
isolate an average intensity value for the Lo or Ld phase.

Figure 2.6 Airyscan general intensity over a representative bead. This figure shows the associated
Airyscan image of the representative bead in figure 2.5. With the resolution increase provided by the
Airyscan modality it is possible to view the relative intensity level differences between the Lo and Ld
phases.

Proceeding the confirmation of the confluent lipid bilayer the next hurdle necessary to
overcome was the aforementioned discrepancy with homogeneity. A key concept of the
supported bilayer approach is the repeatability and normalization of test platforms for potential
use in high-throughput systems. Lipobeads ranging from total Lo coverage to total Ld coverage
have the ability to confound samples specifically tailored to test the effects of lipid
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microenvironment on protein function. In order to test this homogeneity in the samples, 3D zstacks were taken using CLSM, and processed in ImageJ software by making hemispherical
projects of the top and bottom hemispheres of the microbeads. These projections were
thresholded to isolate the bright Ld phase areas, and then overlaid with a mask to normalize for
the loss of geometrical data, when the images was reduces from 3D to 2D in the hemispherical
projections. The thresholded images was then ratioed with the mask to produce a coverage
percentage, signifying the percentage of the hemisphere covered by the Ld phase. Initial tests
were performed by allowing the SUV solution to fuse with the silica microbeads for a maximum
of 30 minutes, but following analysis of these samples, the Ld coverage obtained from these
samples averaged out to approximately 77%± 23% showing a distinct preference for Ld phase
coverage. The standard error shows that the overall variance in lipid phase distribution is very
high, yielding a wide range of lipid microenvironments which is not ideal for a potential highthroughput modality with control of lipid microenvironment. One suggested approach on
refining this variance was to employ the use of flow cytometry, which had been shown as a valid
method to isolate desirable test sets from a varied population of lipobeads. However, since the
average coverage was well above the desired and predicted 50/50 split, garnered from the fact
that there are equal parts SM and DOPC in the lipid formulation, and the prediction from the
phase diagram presented in Dimova et.als. work, it was suggested to extend fusion times before
continuing to cytometry.
As mentioned above, the discrepancy of fusion and heterogeneity problem was the
potential cause of this high Ld phase fusion. It was proposed that extending fusion time to long
times could afford the solutions a better chance to reach an equilibrium and allow for more rigid,
largely SM/cholesterol based liposomes, more time to undergo deformation and fusion with the
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microbead systems. A fusion time of approximately 18 hours, overnight fusion, at 37°C was
tested, and upon analysis of the microbeads, the Ld phase coverage reduced from the 77% above,
to a value of 55% ± 19%, much closer to the desired ~55% from the phase diagram shown in
figure 2.7, this difference can be seen on the lipobead constructs in figure 2.8. Figure 2.9 shows
a histogram of the 2 samples, the short fusion time samples in blue, and the long fusion samples
in red. In this figure it can be seen that overall median coverage has shifted down closer to the
projected 55/45 Ld/Lo split, and an overall decreased spread in overall coverages. To further
understand the effects a long fusion time had on the characteristics of the fused lipid bilayer,
Fluorescence Recovery after Photobleaching (FRAP) analysis was performed on both samples in
the Ld phase. Both of the fusion samples were observed to have a strikingly similar effective
diffusivity of approximately 0.103 ± 0.04 µm2/second for the short fusion lipobeads (n=7), and
approximately 0.104 ± 0.03 µm2/second for the long fusion lipobeads (n=15). The mobile
fraction of the short fusion sample was calculated to be 94 ± 4%, while the mobile fraction of the
long fusion was calculated to be 88±9%. Both of the values, diffusion and mobile fraction, are
not found to be statistically significantly different. This shows, as expected, an extended fusion
time does not negatively impact the diffusive characteristics of the membrane.
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Figure 2.7 Ternary Phase Diagram of the Sphingomyelin:DOPC:Cholesterol lipid formulation.
This is the expected regime in which the SM:DOPC:Chol liposomes will be formed, as well as the
distribution of phases found on the microbead system. It is shown (blue star) that the 40:40:20%
formulation of these molecules should yield an even distribution of both Lo and Ld phases on the
microbeads.

Figure 2.8 Comparative phase separation of short and long fusion times on the
SM:DOPC:cholesterol lipid formulation. This image shows the comparison of the lipobeads fusion step
performed at 30 minute and 18 hour intervals. These are top and bottom hemispherical projections of the
3D images obtained from the LSM800 Zeiss microscope. The phase separation is visible in both
examples, however the 18 hour fusion sample shows a more consistent phase separation from PLB to
PLB.
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Figure 2.9 Histogram of coverage analysis. A histogram showing the overall liquid disordered phase
coverage values of the 18 hour fusion (red) and 30 minute fusion (blue). The blue histogram shows a
population with an average value of 77% ± 23% total Ld phase coverage, while the blue histogram shows
a population with an average Ld coverage of 55% ± 19%. Shown is the normalizing effect a prolonged
fusion step had on the samples overall yielding a tighter distribution of lipobeads as well as one centered
more closely to 50% coverage, the expected value from the ternary phase diagram

Due to the high randomness and interdigitating of the visible phase separation in the
SM:DOPC:cholesterol samples, they were a prime candidate to analyze and test out the
aforementioned super resolution technologies available, STED and Airyscan. The Leica STED
was the first available option to use for this study. However, as seen in figure 2.10, STED did
not yield any increase in resolution in any of the x, y, or z imaged planes. Upon further research
into the STED functionality, due to its use a depletion laser, the fluorescent dyes used in imaging
must be optimized for emission depletion by the available lasers. The depletion lasers available
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were a 592 nm, 660 nm, and 775 nm laser. All three were used to test both the DiO and DiI
probes, but none of them showed any increased resolution, even after deconvolution.

Figure 2.10 Comparison of STED super resolution to CLSM imaging of DiI fluorophore. Shown
here is a comparison between A) base confocal microscopy using a Leica SP8 microscope, and B) a
STED confocal image from the same microscope set up. These images show no visible signs of any
resolution increase from using the DiO/DiO fluorophore lipid tracers as the fluorophore of interest.

The Zeiss Airyscan was the made available shortly after the STED, and its use of a
detector and pinhole array did not require specific fluorophores nor for them to be optimized.
The Airyscan method is more of a mathematical reconstruction method, as opposed to the STED
direct measurement. As seen in figure 2.11, the difference between Airyscan and base CLSM is
a significant increase in resolution. In the highlighted area it can be seen that under base CLSM
imaging, the dark area (Lo phase) is comprised of a combination of both Lo and Ld phases, just at
the resolution limitation of CLSM this area is predominantly Lo and is visually represented as
such. This increase in resolution using the Airyscan technology allows for the refinement of the
coverage analysis to more adequately represent and understand the complexities of phase
separation and in further studies, allow a better quantification of phase and spatial preferences of
reconstituted TMPs.
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Figure 2.11 Comparison of Airyscan super resolution imaging versus CLSM of DiI fluorophore.
This is a comparison of the A) Airyscan imaging technique used on the Zeiss LSM800 to B) confocal
image obtained under the same conditions. The zoomed region highlighting one bead shows further
conclusive evidence that there is a significant resolution increase between the two modalities allowing for
the further elucidation and clarification of lipid phase separation. In these images the green color is the
emission from the DiI FRET acceptor lipophilic probe while the system is illuminated by a 488nm laser.

Throughout these SM:DOPC:cholesterol studies, one main drawback of the system was
considered: the effective biological relevancy of such a basic ternary lipid formulation. It was
necessary to understand what happens when shifting from the BPLE lipid formulation seen
above, to the ternary SM:DOPC lipid formulation. This was tested by creating a series of
SM:DOPC lipid formulations with increasing concentrations of BPLE doped into the
formulation. The system was doped from 0-75% BPLE, specifically 0%, 25%, 50%, and 75% to
determine the effects of increasing the concentration of a more biologically relevant lipid species
would have on the visible phase separation, and later the diffusivity of the lipid bilayer. Figure
2.12 shows the steadily increased dopant concentrations, and it can be seen that when the lipid
begins to shift into a BPLE dominant membrane, starting at 50% doping, the fused lipids become
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unstable on their microspherical solid supports and begin to slough off the microbead and “melt”
onto the coverslip. However, in the samples containing 25% and less BPLE, visible phase
separation is still achieved to a quantifiable degree similarly to the pure SM:DOPC lipid
formulations tested above, indicating that these BPLE systems will provide a new framework to
study membrane protein partitioning in more natural and brain-like lipid microenvironments.

C
B
A

Figure 2.12 Varying BPLE dopant concentration into canonical SM:DOPC:cholesterol formulation.
This figure shows the comparison of varying levels of BPLE lipid mixtures on the structural integrity and
phase separation visibility on normal SM/DOPC/cholesterol levels. Panel A is the 25% BPLE dopant
mixture, Panel B is the 50% dopant mixture, and Panel C shows the 75% dopant. (Displayed using Amira
5.43 using the Volren technique.) At each tested concentration, visible phase separation is present on the
lipobeads constructs, however at concentrations of 50% and above the lipid formulation becomes unstable
in its fusion to the silica microsphere surface and begins to effectively slough off of the surface of the
lipobead and mobile lipids move onto the glass coverslip surface.

Upon doping the SM:DOPC system with lipids extracted from living brain cells, it was
also suggested to look into other possible dopants to increase the diversity of the lipid
environment on the solid supports, while also allowing for the lipid system to more accurately
mimic a biologically relevant system, all while maintaining low levels of complexity and high
repeatability. The second dopants chosen where two fully saturated straight chain lipids, DSPC
and DPPC. Research has shown that when a cell develops cancer, the lipidomics of the
membranes shift wildly from the native healthy cell configurations, and in specific cases such as
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prostate cancer, the amount of saturated lipids, such as DPPC and DSPC, within membranes
increased[105]. To mimic this effect in lipobead systems, we used the SM:DOPC:cholesterol
platform to investigate these changes. Figure 2.13 shows three separate samples containing low
levels of these DSPC and DPPC lipids doped into the membrane. Panels A-C compare the
effects of increasing addition of the long saturated straight chain DPPC and DSPC lipid into the
SM:DOPC:cholesterol base mixture. Panel A is a 0.5% doping of the saturated lipids, panel B
results from doubling the concentration to 1% doping, and panel C results from a 5% doping of
the saturated lipids. Substantial nanoscale phase separation is visible in both the 0.5% and 1%
doping level images but is no longer visible in the 5% doped sample. However, at a level of 5%
DPPC and DSPC it is shown that these lipobeads undergo a phenomenon known as domain
ripening, in which the phases coalesce and separate as much as possible leaving 2 large single
phase structures as opposed to continuously interdigitated nano- to microscale phase separation
we have seen in all of the other lipobead samples of the SM:DOPC:cholesterol formulation. If
this process occurs in cancer cells, it would provide a mechanism for strongly perturbing cell
signaling that could drastically affect malignant cell function and membrane protein partitioning
and dynamics.
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Figure 2.13 Variation of Saturated lipid dopant into canonical SM:DOPC:cholesterol (2:2:1) lipid
formulation. Panels A-C compare the effects of increasing additions of the long straight chain DPPC
and DSPC lipid into the SM/DOPC/cholesterol base mixture. Panel A is 0.5% doping of the saturated
lipids, panel B results from doubling the concentration to 1% doping, and panel C results from 5% doping
of the saturated lipids. Substantial nanoscale phase separation is visible in both the 0.5% and 1% doping
level images but it is no longer visible in the 5%, doped sample. However at a level of 5% DPPC and
DSPC it is shown that these lipobeads undergo a phenomenon known as domain ripening, in which the
phases coalesce and separate as much as possible leaving 2 large single phase structures as opposed to the
continuously interdigitated nano- to microscale phase separation seen in all of the other samples of the
2:2:1 lipid formulation.

Throughout these experiments, FRAP was also performed on a large number of these
platforms. These FRAP experiments provide two key parameters of lipid bilayer fluidity and
diffusivity. These parameters being the mobile fraction and the effective diffusivity of the
photobleached area. In these samples it is expressed as “effective diffusivity” due to the
existence of phase separation within the system, and the evidence suggested in the Airyscan
images, which is that these phases exist below the resolution limitation of the CLSM, and in
further studies is shown to propagate even below the resolution limitations of super resolution
into the nanoscale regime. Figure 2.14 shows a representative FRAP analysis following the
method in Klonis et al.[106]. The results were obtained by photobleaching 1 µm2 areas along
the equatorial region of the lipobeads. Using this cross section of the lipobeads afforded the
ability to analyze multiple instances of FRAP across a single lipobeads, with enough distance
between the bleached areas to avoid any over bleaching or cross talk between the analyzed areas.
The representative FRAP profile in figure 2.14 was developed from a sample fused for 18 hours.
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The x-axis is time in seconds and y-axis is overall normalized recovery. FRAP was performed on
both the visually discreet Ld and Lo phases. The Lo phase shown in here in orange, has low
effective diffusivity at approximately 0.001 µm2/s, ~2 orders of magnitude different to the Ld
phase shown here in black with an effective diffusivity of 0.106 µm2/s.
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Figure 2.14 FRAP analysis performed on SM:DOPC:cholesterol formulation. A representative
FRAP profile developed from a sample fused for 18 hours, the x-axis is time in seconds, and the y-axis is
overall normalized recovery. Frap was performed on both visually discreet Ld and Lo phases. The Lo
phase shown here in orange, has low effective diffusivity at approximately 0.001 µm2/s , a 2 orders of
magnitude different to the Ld phase shown here with an effective diffusivity of 0.106 µm2/s

IV. Conclusions
The work described here shows significant strides in developing a stable, reproducible,
and modular platform, on which effective high-throughput processes can be performed, ranging
from microwell plating assays to flow cytometry. The development of mobile and diffusive
membranes is possible on an array of solid support structures, tested here was the spherical
microbead surface, but the approaches used are rather ubiquitous in nature, and thus could be
applied to various tailored supports including planar and tethered systems. With the rise of
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micromanipulation, 3D printing, lithography, and nanofabrication, there is very little limit to the
potential applications of these lipid systems. A major drive in this work however is to not only
develop synthetic membrane systems, but to increase their biomimetic capabilities while
maintaining key advantages of the synthetic systems.
The highly reproducible, canonical SM:DOPC:chol lipid formulation used throughout
years of lipid studies is shown to be a viable basis on which to build this modular biomimetic
system. It is a widely used baseline mimic in brain membrane studies, and is shown to be highly
effective. However, this is still just a ternary system compared to the tens of thousands of lipid
components found in living cells. By taking this formulation and augmenting it slightly with a
host of varying dopants, it is possible to develop vastly different and compelling
microenvironments more similar to those in living cells, but maintaining Lo/Ld phase separation.
These microenvironments are shown to have substantial effects on TMP function, specificity,
and efficiency. Through the development of more biologically relevant membranes, it is
possible to close the gap between cell culture and low through-put experimental methods and
highly reproducible, rugged, synthetic high- throughput modalities.
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V. Tables
Table 2.1 Additional Materials.
Materials
Name

Atomic Structure

Properties

Perylene
Lipophilic
fluorescent tracer.
Excitation/Emission:
405/ 450
Table 2.2 Lipid formulations. This table contains the overall lipid formulations used throughout the
studies within this work. Due to the fact that the BPLE lipid was a mixture of all lipids obtained from a
lysed brain cell, it was necessary for the formulations to be weight based in their distribution as there was
no equivalent molar weight
Lipid Formulations
Sphingomyelin
40

DOPC
40

Cholesterol
20

BPLE

BPLE doped 2/2/1 1

11.25

10.75

10

34

3

75

BPLE doped 2/2/1 2

22.5

Wgt %

21.75

5.75

50

BPLE doped 2/2/1 3

Wgt %

32.5

31.25

11.25

25

Wgt %

BPLE doped 2/2/1 4

40

39.25

10.75

10

Wgt %

Cancer lipidome test 1

40

30

5

5

20

Mol %

Cancer lipidome test 2

40

38

1

1

20

Mol %

Cancer lipidome test 3

40

39

0.5

0.5

20

Mol %

2/2/1

DPPC

DSPC

BPLE/L-a-PC/chol

41

L-alpha-PC

Basis
Mol %

56

Wgt %

Chapter 3. Gamma Secretase and Substrates in Proteolipobeads
I. Introduction
The transmembrane proteins studied in this work comprised of γ-secretase and truncated
versions of two of its known cleavage substrates, Amyloid Precursor Protein (as SB4) and
Notch-1 (as NTM2). These proteins have a significant impact on disruptive and deadly diseases
and are thus prime candidates for study in the pharmaceutical industry as potential drug and
therapy targets. The work in this chapter was performed by using optimized
SM/DOPC/cholesterol brain lipid analogues, to understand and elucidate key native protein
characteristics such as diffusivity throughout the membrane, potential partitioning of the protein
into one of the two lipid phases, and activity within these synthetic constructs.
II. Material and methods
γ-secretase, the Amyloid Precursor Protein (APP) based substrate SB4, and the Notch-1
based substrate NTM2 were secured from the Li lab at Memorial Sloan Kettering Cancer Center.
Proteins were obtained as extractions from genetically modified cell lines, which causes over
expression of the proteins of interest[107], [108]. All samples were provided as surfactant
stabilized extractions. The surfactant used in these studies is CHAPSO. Table 3.1 shows the
auxiliary molecules used in this section.
Lipobead solid support structures were developed using the aforementioned methods in
the previous chapter. These fused and washed samples were then incubated with the surfactant
solubilized TMP extractions in a 0.25% mixture of CHAPSO for 1 hour at 37°C in the
repurposed incubator, while constantly mixing in an end-over-end rotomixer. γ-secretase was
incubated at 0.07 ng/ml, SB4 at 60µM, and NTM2 at 100 nM, within their respective studies.
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Following the incubation, the samples were then washed thrice, using the same procedure as
above, and fresh PBS.
During the hour long incubation, a mixture of Steptavidin conjugated with Alexafluor
660 (StAv-AF660) was prepared. 25 µl of a 1 mg/ml stock StAv-AF660 solution was diluted
into 10 ml of fresh PBS in a 15 ml conical tube. The StAv-AF660 solution was then subjected to
a Bio-Bead SM-2 Adsorbent (Bio-Rad) clean up regimen in order to remove any unfolded or
damaged proteins ad fluorophores which may non-specifically bind to the protein or lipid
components of the system. After mixing and incubation with the Bio-Beads, the StAv-AF660
solution was passed through a 0.2 micron filter, to remove the Bio-Beads and further eliminate
any unusable complexes. This final 2.5 µg/ml StAv-AF660 solution is further diluted to various
concentrations throughout the experiments herein.
After the washing of the lipobeads systems following incubation with the associated
protein solution, the proteolipobead systems containing APP and Notch-1 were then mixed and
incubated with the StAv-AF660 fluorophore solution in order to label the proteins which have
been reconstituted into the lipid bilayer. The SB4 and NTM2 substrates obtained from the Li lab
have an intrinsic biotinylation site developed in vivo, through genetic modification. This
exposed biotin molecule is used to bind the conjugated StAv-AF660 and thus label the protein
within lipid bilayer in order to track it through CLSM.
Membrane fragments of HEK293 cells containing γ-secretase with the subunit nicastrinpHuji red fluorescent protein (RFP) variant as a C-terminal fusion protein cells were solubilized
with 1% CHAPSO[109]. The solubilized membrane fragments were mixed with the DiO-doped
2:2:1 DOPC/Sphingomyelin/Cholesterol liposomes followed by dilution to give less than 0.01%
final CHAPSO concentration. Centrifugation was used to remove any aggregates to give a clear
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solution of DIO-doped γ-secretase proteolipomes incorporating the subunit nicastrin-pHuji red
fluorescent protein (RFP). These proteoliposomes were fused with 5 μm nominal size silica
microspheres (Bangs Laboratories) for 30 min at a ratio of greater than 10:1 lipid bilayer area to
total microsphere surface area, followed by four wash steps to remove excess proteoliposomes or
any γ-secretase containing membrane fragments or other debris.
III. Results and Discussion
Initial tests were performed with γ-secretase substrates SB4 and NTM2, prior to
experimenting with the larger multi subunit protein γ-secretase. Figure 3.1 shows the overlaid
images of the phase separated SM:DOPC:cholesterol lipid bilayer and the StAv-AF660 labeled
proteins. Using this approach it is relatively straightforward to see the colocalization of the
substrates and the lipid phases. In the samples analyzed within this work, the intensity ratio was
evaluated with respect to the ordered phase. We first form Lo/Ld phase separated lipobeads and
then conduct direct membrane protein insertion, followed by localization with StAv-AF660
(yellow). Then confocal fluorescence microscopy was conducted of substrates loaded into phase
separated PLBs with Lo/Ld microdomain forming SM:DOPC:cholesterol (2:2:1) composition.
Figure 3.1 shows the results of representative confocal laser scanning microscopy (CLSM) 3D
reconstructions. Shown in panels 3.1 A-F are 3D hemispherical projections of a representative
PLBs where the extent of the Ld phase is indicated by DiI (Acceptor) FRET (blue: Panels 3.1A
and 3.1D). The biotinylated labelled substrates SB4 and NTM2 are localized with StAvAF660(yellow), excited by a 633 nm laser line to eliminate crosstalk, displayed in panels 3.1B
and 3.1E respectively. The third column, panels 3.1C and 3.1F, were obtained by merging the
first two columns. We obtained the apparent partition coefficient of the protein (Kp,app) by closer
examination of signal intensities of the Lo/Ld phase partitioning in a random sampling of PLBs of
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each kind (n=10). Using this data, the SB4 substrate partition coefficient Kp,app is 0.55±0.03,
indicating strong preferential partitioning to the DOPC-rich Ld phase (based on
SB4:StreptavidinAlexaFluor660 phase partitioning). In contrast, the non-amyloidgenic Notch
NTM2 substrate shown in the panel shows major loading into both the Ld and Lo phases, Notch
NTM2 substrate partition coefficient Kp,app is 1.03±0.08, indicating only slight preferential
partitioning to the DOPC-rich Ld phase (based on Notch-NTM2:StreptavidinAlexaFluor660
phase partitioning). For reference, a Kp,app value of 1 indicates no preference for either phase.
The differences between Lo/Ld Kp,app were statistically significant in each sample (p < 0.05).
After analyzing this data, it shows that the NTM2 substrate has no distinct preference for
partitioning into either phase of the lipid bilayer while the SB4 substrate shows a minor yet
significant preference for the Ld phase. This preference of the studies of an APP-based substrate
is similar to that seen in previous GUV studies performed by Schlebach et al.[110]
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Figure 3.1 Colocalization of TMPs and Ld phase highlighted lipid membrane. A&D) Phase separated
SM:DOPC lipid bilayers shown here fused to a microbead. B&E) SB4 and NTM2 substrates shown here
are reconstituted into the lipid bilayer and then fluorescently labeled with a StAv-AF660 molecule to bind
to any exposed/outward facing biotin site. C&F) a merge of the 2 channels to show colocalization of SB4
in the Ld phase, and no apparent partitioning preference for the NTM2 molecule.

During the implementation of γ-secretase supported biomembrane systems, the Li lab developed
a new modified version of the γ-secretase complex which is expressed containing a pH
dependent red fluorescent protein (RFP). Specifically, the enzyme complex contains NicastrinpHuji red fluorescent protein (RFP) variant as a C-terminal fusion protein. These constructs were
developed in a cell modified to show significant upregulation and over expression of γ-secretase.
A benefit of RFP is that it is a highly optimized fluorophore for use in the STED super resolution
modality. Figure 3.2 displays STED and CLSM microscopy of a representative HEK293 cell
over expressing γ-secretase labeled with RFP (as pHuji). The 3D reconstruction displays a
representative HEK293 cell that contains overexpressed γ-secretase visualized due to
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incorporation of the subunit nicastrin-pHuji red fluorescent protein (RFP) variant as a C-terminal
fusion protein. Optical sectioning of the 3D cell was used to isolate the plasma membrane
localization of γ-secretase, shown in the insets. A comparison of the same z section in CLSM and
STED shows the significant resolution increase obtained. The diffusivity of the γ-secretase
protein in the plasma membrane was obtained through FRAP and determined to be 0.025
µm2/sec (as shown in figure 3.3) with a mobile fraction of ~79%. To our knowledge, these
studies constitute the first diffusivity measurements of γ-secretase. The γ-secretase from these
cells was then extracted from membrane fragments in 1% CHAPSO and proteoliposomes were
formed. The 2:2:1 DOPC/Sphingomyelin/Cholesterol lipid formulation doped with DiO tracer
was used to form proteoliposomes. PLBs were formed via proteoliposome fusion and the
assemblies were characterized with CLSM and confocal-FRAP. Figure 3.4 displays a
representative PLB with the supported lipid bilayer imaged via DiO (green) and the γ-secretase
localized via RFP-pHuji (red). Highly homogenous supported bilayers were formed. In this case,
no significant signs of phase separation were evidenced under these conditions, presumably due
to the complex mixture of MPs and endogenous lipids that accompany the CHAPSO extraction
and proteoliposome construction. Figure 3.5 displays a comparison of DiO and RFP FRAP
performed on the supported bilayers formed on silica microspheres as PLBs. The red data points
and fit (right) are from the γ-secretase FRAP and the green data points and fit are from the DiO
lipid tracer. The γ-secretase signal yields an effective diffusivity of 0.017 um2/s with a mobile
fraction of 80%, slightly lower than that obtained from the HEK293 cell. These studies constitute
the first diffusivity measurements of γ-secretase in supported lipid bilayers. One aspect of this
disparity between the live cell diffusivity and lipobead effective diffusivity is the unknown phase
composition of the lipobead versus the live cell membrane, as shown in the previous chapter the
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phase mobility is approximately two orders of magnitude different between the two predominant
phases, Lo and Ld. Another aspect to consider is the effect of interactions between the protein
and the solid support structure, this interaction is addressed later in this research. However, the
lipid tracer DiO yields an effective diffusivity of 0.083 um2/s with a mobile fraction of ~80%,
establishing that the extracted γ-secretase does in fact insert into the intact lipid bilayer of PLB
constructs, which is well within the range of effective diffusivity from the previous chapter.

Figure 3.2 STED and CLSM microscopy of a HEK293 cell over expressing γ-secretase labeled with
RFP (as pHuji). The 3D reconstruction displays a representative HEK293 cell that contains
overexpressed γ-secretase visualized due to incorporation of the subunit nicastrin-pHuji red fluorescent
protein (RFP) variant as a C-terminal fusion protein. Optical sectioning of the 3D cell to isolate the
plasma membrane localization of γ-secretase is shown in the insets. A comparison of the same z section
in CLSM and STED shows the significant resolution increase obtained.
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Figure 3.3 FRAP analysis of in vivo γ-secretase within the HEK293 cells. This figure shows the
relative FRAP of the pHuji RFP tagged γ-secretase complex examined within the plasma membrane of
the HEK293 cell under observation. This analysis yields an effective diffusivity of ~0.025 µm2/s with a
mobile fraction of 79%

Figure 3.4 Extracted RFP-tagged γ-secretase reconstituted in PLBs. Reconstituted cell extracts from
the HEK293 cell containing γ-secretase, obtained using the 1% CHAPSO cellular solubilization method
typically used to purify the complex from mammalian cells to form proteoliposomes. . The 2:2:1
DOPC/Sphingomyelin/Cholesterol lipid formulation doped with DiO tracer was used to form liposomes
that were used to obtain PLBs via fusion, pictured above in 3D reconstructions from the CLSM. In this
case, no significant signs of phase separation were evidenced under these conditions. Scale bar is 1µm.

49

Figure 3.5 Effective FRAP analysis on RFP and DiO in the HEK293 extract PLBs. A comparison of
DiO and RFP FRAP performed on the cell extracts reconstituted on the silica microspheres. The red data
points and fit is from the γ-secretase FRAP and the green data points and fit are from is the DiO lipid
tracer. The γ-secretase signal yields an effective diffusivity of 0.017 µm2/s with a mobile fraction of 80%,
and the DiO yields an effective diffusivity of 0.083 µm2/s with a mobile fraction of 80%

IV. Conclusions
Shown here, protein direct insertion into the lipid bilayer is a viable and readily usable
approach to studying isolated TMPs under controlled conditions. While these systems are not a
direct measurement from a biological source, these platforms are comparable as they maintain
mobility and activity, as seen in various assays performed by the Li lab. While it has been
shown that overall diffusion is reduced in these supported bilayer systems, it is possible to
account for the overall differences between cell and synthetic systems. This approach can also
yield reliable and necessary values for future modelling work on these complex spatial reactiondiffusion protein systems.
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The ubiquitous nature of the approach through all of the aforementioned studies leaves
this as a highly modular and interchangeable system. This flexibility in design can allow for the
study of any and all TMPs that can be successfully extracted from cells and reconstituted without
significant loses. This approach to TMP study has the potential to revolutionize pharmaceutical
discovery and trials by allowing for the direct testing of these proteins in controlled lipid
environments with exact concentration measurements of both enzyme and substrate on a rugged
platform. In this system, single protein pathways can be isolated and studied without the use of
genetically modified and augmented cells, in an environment which maintains biological
relevance while affording high levels of control and heterogeneity.
However, this process is not completely ubiquitous as a few minor changes to the lipid
formulation, or protein studied can have a marked effect on the effectiveness of this exact
approach. Each time a modification would be made, a new cycle of optimization would have to
be attempted. In some cases this approach is a tedious downfall of the system, but overall these
changes are not substantial or large changes, and overall the modifications needed to develop a
new platform for a different TMP would include finding the proper fluorophore label and what
concentration range works best for the given microenvironment. This optimization can be easily
performed through the use of high throughput screening systems, for which these platforms are
expressly being developed.
This work shows that reproducible, and mass produced, test platforms for TMPs can be
created simply and reliably. These platforms are robust, and rugged enough to undergo varying
forms of mechanical processing such as the washing, to eliminate unfused lipids and noninserted or unfolded proteins, up to flow cytometry. The ability to produce and examine these
samples in tandem on planar surface and microspheres allows for further characterization of
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these structures and has advantages over other TMP testing platforms such as GUVs, solubilized
protein mixtures, or cell culture studies. γ-secretase proteins and, SB4 and NTM2 substrates, are
all shown to directly insert into the lipid bilayer and maintain key biological relevancy factors
such as mobility and phase partitioning. These platforms also allow for the removal, via
washing, of key non-biologically relevant substances, such as detergents, which have unknown
direct effects on these proteins and their structures and interactions.
V. Tables
Table 3.1 Additional Materials
Materials
Name

Atomic Structure

Properties

APP analogue,
contains a
biotinylation and
FLAG antibody site

SB4

NTM2

Notch-1 analogue,
contains a
biotinylation site
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Chapter 4. Tethering modalities
I. Introduction
In this chapter, the focus is on the use polymer moieties to produce complex yet elegant
tethering systems. Tethering is a process by which a solid support structure is chemically
augmented to both minimize surface interactions between the support and the system it is
supporting, in this case a lipid bilayer, and provide additional functionality to the solid support.
It is posited in this work, that functional tethers can be developed and implemented on solid
silicon dioxide surface for use with a canonical brain cell-analogous lipid structure. The two
functionalities approached in this work was a tethering modality which fundamentally provided
the lipid bilayer with numerous anchor points to facilitate a pseudo-binding between the glass
surface and the bilayer, and a modality which could preferentially sequester proteins which
express a key binding domain towards the silicon dioxide surface as opposed to the expressing
this domain outward away from the support. These two orientations of the protein are facilitated
by the direct insertion method used in studies explained in an earlier chapter.
II. Materials and Methods
Glass slides, coverslips, and silicon dioxide chips were cleaned overnight in Piranha
solution, the supports were then washed thoroughly with DI water as stated above. (3Aminopropyl)trimethoxysilane (APTMS) was then mixed to varying concentrations with DI
water, toluene, and ethanol. In this study the mixtures all contained 5% APTMS v/v within the
three solvents. The glass and silicon dioxide surfaces were then immersed in these solutions in
order to develop a deposited layer of the APTMS solution in a process known as silanization for
a total of 30 minutes. One test was performed by placing the clean glass supports in a vacuum
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chamber with pure APTMS in an open container, the chamber was then placed under a slight
vacuum, just enough to completely seal the vessel, and let to sit for 30 minutes. This process
subsequently leaves a chemically attached amine group on the surface of the solid support. The
amine is then used to undergo a series of amine to N-hydroxysuccinimide (NHS) dehydration
reactions in order to develop a step by step layering of tethering polymers[111].
Specifically used in these studies were varying chain lengths and shapes of poly(ethylene
glycol) (PEG) polymers purchased from Nanocs, Inc. Also various NHS linkers and conjugates
were used throughout the studies. After the silanization step, the supports were then treated with
either NHS-PEG4-Biotin, NHS-PEG2000-DSPE (DSPE: 1,2-disteroyl-sn-glycero-3posphoethanolamine), both at 0.5 mg/ml in DI water, or a solution of a homo-bifunctional
crosslinker bis(sulfosuccinimidyl)suberate (BS3), at 0.2 mg/ml in DI water. The BS3 supports
were then further treated with a solution contained Amine terminated PEG chains of varying
molecular weights and shapes, at a consistent concentration of 1 mg/ml in DI water. The most
predominant linker used in these studies was the 4-arm star PEG polymer at a molecular weight
of 20,000 Daltons (4armPEG20000-NH2). This star polymer was then capped with one of the
previously stated capping agents.
Biotin and DSPE were chosen to be the tether ends due to their desired functionality
within the systems studied. Biotin is a molecule which binds strongly and quickly to the
molecule Avidin, named due to this high avidity relationship. In these studies, Streptavidin was
used as the binder to the adhered biotin molecules. Streptavidin was chosen due to its innate
resistance to detergents, which are used primarily in future process described herein.
Streptavidin conjugates are commercially available, this affords the ability to label and visually
inspect the degree of tethering, and allows for additional use of the streptavidin-biotin affinity as
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the streptavidin molecule contains 4 biotin binding domains per molecule. The DPSE capped
tether is used for direct insertion in to the lipid membrane. During tests in which small
unilamellar vesicles (SUVs) are fused to the surface of these supports, the DPSE lipid can insert
itself into the lipid bilayer facilitating and promoting vesicle fusion and anchor points to attach
the bilayer tenuously to the solid support. Figure 4.1 shows the effective modular linking process
and final product schematics.

Figure 4.1 Schematic of effective tethering linkages. This figure shows the effective modular tethering
support structure, the far left image depicts the base tethering structure of silination of the glass surface
leaving amine residues followed by a small linking molecule to which a large polymeric moiety is
attached. The middle schematic depicts the capping of the previous tether with the lipid anchoring
functional end piece, while the picture to the right depicts the Biotin expressing functional cap which is
then further utilized through the introduction of the streptavidin molecule.

Using this system of NHS-Amine ester linkages, allows for the development of a modular
tethering system, similar to building blocks. At each consecutive step molecules can be
introduced, deleted, or augmented in order to develop a more apt tethering moiety for the
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designed purpose. This linkage can also be carried out in water without the help of any ancillary
chemicals to add complexity and potential harm to more delicate platforms, such as biological
systems. Tests were performed using various different tethering moieties with this modular
technique to develop various platforms. 4 arm PEG20000-amine was the predominant second tier
linker, but other amine-terminated PEG polymers were used throughout this study ranging from
straight chain polymers, to 8 arm star polymers, from 2kDa up to 20kDa.
III. Results and Discussion
Throughout these studies, the most important concept for the use of tethering was the
development of a polymeric cushion on the surface of these solid supports. Untreated glass and
silica beads can have varying degrees of roughness on the nano and micron scale, and this
roughness has the potential of creating diffusion “wells” and barriers which prevent proteins and
other molecules from properly moving throughout the lipid bilayer, and can even perpetuate the
coalescence of domains artificially within the bilayer. As shown in previous work from this
group, the use of polymer cushions can have a significant effect on the overall diffusivity of
lipids and proteins within the supported lipid bilayer. Specifically in the experiments shown
here, the biotin tag and the DSPE cap were used as added functionalization on top of the
development of the polymer cushion.
The biotin capped samples were the first attempted tethers in this study. It was the
original goal of this work to develop a system in which non-biologically relevant protein
orientations could be sequestered and ultimately removed from the PLB and planar surface
testing of these TMPs. Proteins inherently have a specific orientation within the cell, which is
controlled in vivo during protein transcription, with the extensive use of chaperone proteins and
directional transcription, proteins maintain their specified orientation within the framework of a
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cell. However, in these studies the proteins are reconstituted into synthetic membranes through
the process of direct insertion. This method does not yield a constant or specific orientation to
most of the proteins inserted into the lipid bilayer. This inevitably means, in any direct insertion
of proteins into a supported bilayer, that the resulting biomimetic membrane contains a mixture
of biologically relevant protein orientations as well as the opposite orientation.
The SB4 and NTM2 substrates used in later tests, developed by collaborators in Dr.
Yueming Li’s lab at Memorial Sloan-Kettering Cancer Center, contain a built in biotinylation
site which natively adds a biotin molecule onto the N-terminal side of the protein. The APP
molecule also contains a FLAG antibody binding domain on the C-terminal side of the
transmembrane helix. This directionality in design was the target of the biotin capped tether
studies, due to the ability of the streptavidin molecule to bind multiple biotin molecules. Figure
4.2 shows the effective development of a tethered glass surface coated with a layer of
streptavidin which had been conjugated with Alexafluor 660, a red fluorescent molecule. This
planar surface was developed by using an APTMS->BS3->4armPEG20000-NH2->NHS-PEG4Biotin modular structure, to which a biomimetic lipid bilayer was fused and lipid coated silica
microspheres were then introduced. This proof of concept shows that it is possible to develop
systems containing both planar supported bilayers and lipobeads in tandem as well as the ability
to label one surface with the biotin capped tether while allowing for the secondary structure, in
this case the microbead, to contain different functional tether, such as the DSPE capped tether.
This platform could allow for the sequestration of the non-biologically relevant oriented protein
by effectively capturing the N-terminal exposed biotin and eliminating the potential for lateral
diffusion throughout the system. In this scenario, those proteins with biological orientation
maintain the ability for lateral diffusion throughout the lipid bilayer and support structure.
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Figure 4.2 Validation of the Biotin capped tethering modality. This figure is an Amira reconfigured
3D image taken from a sample in which the glass surface was treated and the biotin expressing tethering
moiety was developed. A) The isolated red signal shows the coverage of the glass surface with a
streptavidin molecule which had been conjugated with an Alexafluor 660 fluorophore. B) The greenishblue section is a SM/DOPC/cholesterol lipid bilayer containing a lipophilic tracer (DiO) which was fused
onto both the planar bilayer support as well as microbeads visible in this image.

The use of tandem planar supported bilayers and lipobead constructs have the potential to
isolate the proper protein orientation, thus that the improper orientation will diffuse and then
become pinned on the support containing the streptavidin molecules, and when allowed to reach
an equilibrium should provide that one support structure contains predominantly relevant
proteins while the secondary structures contains the oppositely oriented proteins. The lipobeads
supports can then be removed from the solid support thus yielding either a planar support or
lipobead system containing the proteins of interest, depending on the further application of the
platforms.
The second approach to tethering came through the DSPE capped tethers in an attempt to
create a more rugged and robust platform in order to further the possible use in high-throughput
techniques. The addition of the DSPE cap onto the polymer cushion using NHS-PEG2000-DSPE
would allow for the lipid bilayer to essentially contain an anchor point to the solid support
structure. In early tests performed on this work, it was seen that the lipid bilayer, when fused
directly to the solid support structures, was very tenuously adhered to the support structure. If
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samples underwent varying forms of stress outside of delicate handling techniques, the result
could be that the lipid bilayer could wholly or partially slough off of the surface of the support.
With DSPE lipid inserting itself into the bilayer during the fusion process, and the DPSE
molecule being chemically attached to the solid support structure, this tethering structure has the
capacity to relieve stresses on the bilayer by transferring the stresses into the PEG cushion and
further onto the solid support while maintaining overall mobility of the lipid bilayer.
A major difficulty of this approach is that there is no visual marker of this tethering
moiety unlike the tethers using the Alexafluor conjugated to streptavidin, making this DSPE
capped structure unidentifiable under CLSM. In order to inspect this tethering moiety AFM was
used to gather information on the presence of the tethered structure. Two approaches were taken
with the AFM, a puncture test using the probe tip to depress through the lipid bilayer and the
polymer cushion in order to deflect against the solid support beneath, and a tapping imaging
mode in order to view the intact membrane on the surface of the support. The puncture test seen
in figures 4.3 and 4.4, yield distinctive patterns when a lipid bilayer and polymer cushion is
present on the surface of the planar support structure, as described by Alessandrini et al[112].
There is a constant, linear force exerted on the tip as it passes through the PBS buffer. Then,
close to the support there is a small upward tick in the deflection of the probe tip, followed by a
small window of undulation, culminating in the linear increase of deflection indicating that the
solid surface has been reached. The brief increase in deflection is the tip coming into contact
with the lipid bilayer, and the undulation following is the tip effectively moving through the
bilayer and the polymer tether. The distance of the initial deflection to the steep deflection
caused by the solid support and the force necessary to break through the bilayer are the important
characteristics of this test. The distance between the “infinite force” line and the initial increase
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in deflection yields the relative height and thickness of the bilayer and polymer cushion together,
understanding the lipid composition of the bilayer, and estimated thickness can be assumed and
thus any extraneous distance between initial deflection and the solid support is the relative
thickness of the polymer cushion. In the figures below, the effective tether and bilayer
thicknesses are calculated to be 64.1 ±10.2 nm for the 4-arm PEG 20K sample and 5.6 ±1.6 nm
for the PEG2000-DSPE tether which is comparable to the results obtained by Hertrich et al[113].
In this PEG2000 case, the thickness is larger than the Flory radius (3.5 nm). The force obtained
from this deflection is ultimately the force required to puncture the lipid bilayer fused onto the
support. It is suggested with this information that a chemically deposited PEG tethering support
structure was created on the surface of the silica microscope slides.

Figure 4.3 Overlay of indentation tests performed on glass microscope slides containing a 4-arm
PEG20000 star polymer tether connected to a SM:DOPC:cholesterol lipid bilayer. Indentation tests
were performed on a system similar to that shown in figure 4.1 as the lipid tether containing the large 4arm PEG20000-NH2 star molecule. Analysis shows that the separation distance from the average
breakthrough height to the glass surface is approximately 64 nm.

60

Figure 4.4 Overlay of indentation tests performed on glass microscope slides containing a single
PEG2000-DSPE polymer tether connected to a SM:DOPC:cholesterol lipid bilayer. Indentation
studied performed on a system containing only one polymer tether building block, the NHS-Peg2000-DSPE
only. These indentation studies show that the average distance between the membrane and the solid
planar support is approximately 5.6 nm

Using the tapping imaging mode of the AFM, it is possible to verify the presence of a
confluent lipid bilayer. This imaging method converts the received deflection information from
the AFM probe into a height map of a scanned area. This height map can then be viewed as an
image of the surface being scanned by the probe tip, using relative height differences of the
scanned area it is possible to discern systems of phase separation and individual protein
molecules imbedded in the lipid bilayer. Figure 4.5 shows a 3D reconstruction of the tapping
mode height readout on a glass microscope slide. It is visible here that the surface roughness of
microscope slides has a negative impact on the smoothness of the lipid bilayer, even with a
moderate level of tethering. Phase separation is impossible to determine under these conditions,
while it is readily apparent on the Ultra-flat thermal oxide wafers. Coupled with the puncture
test data, a confluent lipid bilayer can be shown with a given height away from the solid support
structuring, giving ample evidence of a tethered lipid bilayer system. The tapping imaging mode
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of the AFM is used in future studies found here to discern protein partitioning and phase
separation on planar systems, in order to gain a two-fold approach to understanding the complex
spatial and diffusive system of γ-secretase and its substrates.

Figure 4.5 3D reconstruction of a tapping mode AFM scan of a glass microscope slide containing a
4-arm PEG20000 tether connected to a SM:DOPC:cholesterol lipid bilayer. A 3D reconstruction of a
sample on a silica microscope slide treated with a tethering construct similar to that seen in figure 4.1 the
lipid tether containing the large 4-arm PEG spacer. Microscope slides show an incredibly large level of
roughness on the AFM scale, and at this level simple tethering technique do little to help minimize the
overall roughness of the support.

The ultimate goal of this project is to embed γ-secretase and it substrates into these
systems. Figure 4.6 shows AFM data from the 37ºC reconstitution of γ-secretase into preformed
sphingomyelin:DOPC:cholesterol (2:2:1) supported bilayers with polymer cushion tethering
using 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-PEG2000-succinimidyl ester (NHSPEG2000-DSPE). Tapping mode image of a PEG2000-DSPE tether supported phase separated lipid
bilayer with inserted γ-secretase on a thermally oxidized silicon wafer. Panel A is AFM tapping
mode image obtained from imaging a tether supported SM/DOPC/cholesterol lipid bilayer, with
inserted γ-secretase proteins. The liquid ordered and disordered phases of the lipid bilayer can
be seen here in the two distinct light and dark brown regions. The single star (*) here denotes γ-
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secretase in the Lo phase, while the double star (**) is an indications of a γ-secretase molecule
suspended in the Ld phase. Panel B is a set of height profiles of features consistent with single γsecretase complexes embedded in the tethered bilayer, including the ones indicated with * and **
in panel A. A Nicastrin molecular volume of 147 nm3 was obtained using the polymer size
versus chain length arguments made by Saslowsky et al and the feature size obtained here is
164±23 nm3, in line with the expected protruding volume of the Nicastrin domain [114]. The
incorporation levels are lower than desired, however, we will further tune the conditions in future
experiments.
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A

B
Figure 4.6 Tapping mode image of a PEG2000-DSPE tether supported phase separated lipid bilayer
with inserted γ-secretase on a thermally oxidized silicon wafer. Panel A is AFM tapping mode image
obtained from imaging a tether supported SM/DOPC/cholesterol lipid bilayer, with inserted γ-secretase
proteins. The liquid ordered and disordered phases of the lipid bilayer can be seen here in the two distinct
light and dark brown regions. The single star (*) here denotes γ-secretase in the Lo phase, while the
double star (**) is an indications of a γ-secretase molecule suspended in the Ld phase. Panel B is a set of
height profiles of features consistent with single γ-secretase complexes embedded in the tethered bilayer,
including the ones indicated with * and ** in panel A. This analysis yields a feature size of 164±23 nm3
which is in line with the expected volume of a protruding Nicastrin domain of 147 nm3.
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IV. Conclusions
Tethering is a viable, and in some cases necessary, approach to supporting biologically
relevant synthetic systems. Tethers promote a more fluid and biologically equivalent system by
helping to negate any artificial affects caused by the solid support, which are not present in cell
systems. Effects ranging from roughness to electrostatic interactions to pinning of a protein
containing non-negligible intra or extra cellular domains. Tethering systems also afford the
ability to functionalize the solid support while not seriously affecting the fluidity or rigidity of
the synthetic platform.
It is shown from this work that it is possible to develop tethered support systems using
straightforward and simple NHS-Amine crosslinker chemistries, which yield highly modular and
adaptive moieties. The ends of these moieties can be functionalized to promote various effects
deemed desirable to the application of these systems. Shown in this study are the effective
labelling of the tether moieties, and potential use for protein sequestration, and the process by
which cushion thickness can be obtained in order to verify the presence of the tethering moiety.
This work lays the foundation for further exploration into the usefulness and potential
functionalization for tethered surfaces. In future studies discussed within, AFM is performed on
two distinct platforms, mica and the glass surfaces described above. These two platforms are
vastly different in both charge and roughness which can lead to markedly different systemic
results and these disparities can be effectively eliminated through the use of tethering. Mica is
atomically flat, but contains a high charge density, while the glass surfaces have significantly
higher roughness but with an overall lower charge density. The PEG cushion can dampen the
effects of the surface charge interactions of the mica by creating spatial separation between the
solid support and the lipid bilayer through which these electrostatic interactions cannot span.
65

The cushion can also minimize the effects of surface roughness on the glass supports by
essentially filling in the “wells” and normalizing the surface to be a uniform roughness.
Developing a complimentary tethered system using both supports could allow the qualification
of using planar glass supports in AFM studies, since currently mica platforms are preferred in
these studies due to their flatness. Use of planar glass supports allows for the further edification
of an in tandem approach of using AFM on planar surfaces to characterize identically treated
microbead systems, which offers increased capabilities in terms of high throughput techniques
and other important biological assays.
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Chapter 5. Conclusions and Future work
Throughout this process, highly specialized and biological lipid biomes were researched
and emulated in order to produce a synthetic, homogeneous, controllable platform on which to
perform TMP assays for potential use in high-throughput screening and study techniques
important to the pharmaceutical industry. TMPs are one of the more difficult family of proteins
to study and for the development drug modifications, due to the necessity of these proteins to
remain within a confluent lipid bilayer so as to not denature and lose functionality. Current
techniques available for the testing of TMPs on a large scale are not optimized and in some cases
not possible to be utilized in high-throughput fashion. Cell culture studies are difficult to
control, even with techniques such as genetic modification, and in most cases are intensely
resource heavy to facilitate. Other intact biomembranes approaches such as GUV,
proteoliposomes, or GPMVs, do not have the specificity or ruggedness to be used in a highthroughput format or in flow cytometry. The approaches shown in this work afford a relatively
simple and effective option containing important factors from these other techniques.
Tethering systems are not a predominantly used technique in the field of TMP and lipid
systems research, due to the fact that most test platforms do not utilize the solid support
structures on which this research relies. These solid support structures, microbead and planar
systems, while a readily viable platform for use in these protein studies as shown, can be
augmented to more closely resemble and match key characteristics of the biological
environment. In previous work it was shown that tethering large PEG moieties onto silica
surfaces facilitated an environment with a higher overall diffusivity, the work performed herein
shows that similar tethering moieties can be developed in a modular, building block like
approach in order to help eliminate surface interactions of the lipid and protein with the solid
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support, as well as introduce functional molecules onto the ends of these polymer cushion to
increase overall assay and platform performance.
SM:DOPC:cholesterol lipid systems have been widely used as a brain cell analogue in
various biological and protein studies throughout the past decade. This system yields a key
advantage for studying systems such as γ-secretase and its substrates, where under specific
conditions this lipid formulation forms two distinct semi-miscible phases, liquid ordered and
disordered. This phenomenon is highly desirable as it has been shown that effective cholesterol
levels in cells has an effect on the cleavage efficiency and specificity of proteins like γ-secretase.
Using this lipid formulation, the work described shows that not only can a confluent lipid bilayer
be deposited on various solid structures, but also that the effective phase separation can be
visually studies and quantified. This aspect of the SM:DOPC:cholesterol lipid formulation is
indispensable in the study of TMPs as each phase has substantial differences which can have
marked effects on protein performance as a function of lipid microenvironment. Understanding
key factors such as preferential partitioning of proteins, diffusion speed, and activity within
given environments can readily be obtained with the systems developed. In addition to the
SM:DOPC:cholesterol lipid formulation, it is shown that this canonical analogue can be
modified with more complex lipid structures and cell extracts, yet still maintain this visible and
quantifiable phase separation. This has led to the development of systems which are much closer
to biological relevancy in terms of overall lipid environment and yield important spatial
information about the lipid microenvironment and eventually proteins.
Direct protein insertion into a confluent lipid bilayer with the help of specialized
detergents, namely CHAPSO, is a straightforward a reproducible process on both the planar
supported bilayer and the lipobeads constructs. The process described in this work affirms the
68

ability to directly insert γ-secretase protein, SB4 and NTM2 substrates into a canonical
SM:DOPC:cholesterol lipid bilayer. The insertion of these proteins into the lipobead and planar
supported bilayer systems allows for the study of apparent phase partitioning of the proteins,
protein localization, diffusivity, characterization of enzyme and substrate concentrations for
elucidation of enzyme kinetics, and flow cytometry or other high through-put assays. This work
was completed on γ-secretase and two of its substrates; however, this process is not restrictive to
these three proteins. The procedure and treatment of the proteins in order to insert them into the
lipid bilayer was not augmented between the three significantly different proteins. The fact that
this procedure is unchanged between tests is a positive sign for the possibility of using these
formulations and this detergent for a wide range of TMPs and other biological moieties which
require a confluent bilayer in which to be studied in a relevant manner.
The experiments performed herein developed a malleable platform on which to perform
this protein analysis on γ-secretase and its substrates. It was approached in a way to initially test
if this process of lipid fusion of the SM:DOPC:cholesterol was applicable to silica microbeads
and planar bilayers, followed by the introduction of proteins into the platform. Upon
determining that this basic approach was valid, the optimization and bilayer changes then
became a focus. For this reason, the more complex, doped lipid systems are in early stages of
development and study to fully understand their usefulness and applicability to the tests
described. This however is the first work performed to our knowledge of the development of
proteolipobead systems with phase separation and lipid configurations with high levels of
biological relevance, for the use in studying γ-secretase and two of its substrates. The basic
system of SM:DOPC:cholesterol displays the ability to reconstitute mobile and active purified
protein extracts on a platform, shown in previous studies, designed for use in a multitude of high-
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throughput screening studies used heavily in the pharmaceutical industry. This simplified
systemic approach is bolstered through the ability to be highly modular along every step of the
process. Each step of this work is built for flexibility, from the building block aspect of the
tethering support structures, to the canonical brain cell analogue, which still retains its beneficial
qualities, doped with various more complex lipid systems used to model assorted biologically
relevant lipidomes, and finally to the direct insertion of the γ-secretase and substrates into the
lipid bilayer, a process which is not specific to the proteins studies and is an ubiquitous approach
to TMP insertion into membranes. The tandem approach of studying these systems under both
CLSM and AFM, while still in its infancy, is a highly effective tool in understanding and
characterizing the lipid environment and understanding the details and dynamics of the system
on the nanoscale.
Going forward, these systems do require further study and understanding before they are
deployable test beds for an array of protein testing. The research here lays the groundwork
required for the development of model and modular systems, though many more building blocks
are necessary to develop a full-fledged analytical high-throughput testing modality.
Firstly, on the topic of tethering, it would be important to understand the effectiveness of
tethering on solid supports outside of the silica glass based supports tested here. A litany of
materials are currently used in biological studies, each could afford a new and unique approach
to developing tethering moieties with high functionalization, but specifically for this work
understanding and eliminated the differences between mica and silica surfaces for AFM use
should minimize the discrepancies seen between the two modalities. In line with the further
tethering studies, optimization of the tethering procedure for use on the microbead systems is
required, all studies in this work were performed on planar silica glass surfaces and all
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microbead studies did not yield highly reproducible lipobeads constructs. It would be pertinent
to know the effect these tethering moieties have on these specific proteins in terms of the PLB
constructs. The testing performed in this work primarily focused on the idea of sequestering the
non-biologically relevant protein orientations in an attempt to eliminate them from any further
experimental steps and was not continued through the entirety of the research reaching to the
protein insertion steps. Similar tethering systems have been studied previously in this lab
showing that this tethering did not heavily disrupt the protein insertion procedure, so this was
considered a non-issue throughout this work.
Secondly, on the topic of confluent lipid bilayers and fusion techniques and fluorescent
labelling. This work touches on the a small window of potential modifications to the canonical
SM:DOPC:cholesterol system, dopants such as BPLE, DSPC, and DPPC studied here are minor
changes to the core system, however they still build platforms which are arguably very different
from the lipid micro/nano environment these proteins experience within cell membranes.
Continual study of relevant cellular lipidomes is necessary to build controllable, simplified, yet
still relevant biological systems that maintain protein function and are highly relatable to the cell
functionality. In this work, the DiO/DiI FRET method was used to understand phase separation,
lipid mobility, and coverage of the solid supports. This method does have its disadvantages,
which became apparent throughout this work particularly in that these molecules are a
predominantly single phase label, these molecules are not STED applicable fluorophores, and
they take up a large window of the available detector bandwidth. A complimentary fluorophore
to label the Lo phase would further validate the work here and help elucidate the two phase
system. While Airyscan is an effective and highly functional super resolution method, having
the ability to validate the phases on two separate systems is beneficial. The combination of the
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FRET pairing required a detector imaging window from 500-600nm, this window is in the very
center of the available spectral space. The proteins tested in this work were all labeled with the
binding of a conjugated streptavidin to a biotin molecule, this process is straightforward, but as
shown can contain variance. Other labeling systems can be studied, including but not limited to
antibody labeling, genetic modification to include fluorescent proteins, and direct labelling prior
to protein insertion.
Finally, on the topic of protein insertion and assays, the protein work completed in this
research revolved around use in the canonical SM:DOPC:cholesterol lipid formulation, as this
was the best studied and most optimized formulation throughout the entirety of this work. This
lipid formulation while robust and effective, is still only a ternary or pseudo-ternary system
compared to a biological system with upwards of 10,000 varying components. Testing of these
proteins in the doped samples developed in this work could be useful in elucidating whether
these more complex systems will be more effective in understanding the protein functionality in
cell systems and verify a correlation between these developed synthetic systems and the cellular
environments in which these proteins reside. Also suggested would be the testing of these
proteins on more tethered surfaces, both in complexity and in structure. Furthermore, testing of
this direct insertion method using the CHAPSO detergent on other more variable protein will
determine the extent of use. γ-secretase is a multi-subunit with 19 helical passes through the lipid
bilayer, while both APP and Notch-1 are comprised of a single helical pass through the bilayer
with both intracellular and extracellular extremities. This range in proteins tested does suggest
that a large variety of TMPs would follow the same pattern of facilitated insertion into the
lipobead systems, however variations in size of the transmembrane portion, large or highly
charged extra/intra cellular domains, and varying secondary/tertiary/quaternary structures of
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TMPs may impose further difficulties on this procedure. In the case of studying a wider range of
proteins, this aspect is closely tied with the further development and optimization of a wider
variety of synthetic membrane analogues. Together the eventual goal of this work is to build a
catalog of proteins and lipid membrane analogs which can be selected and prepared readily to
closely mimic a highly reproducible biologically relevant environment through close control and
synthetic means.
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